# PeptideScanner evidence objects: Vosoritide

Every published version of the records placed with Vosoritide, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/vosoritide.json. Selected public evidence only; not medical advice.

- Objects: 57
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct02055157-vosoritide-v1"></a>

## ClinicalTrials.gov record NCT02055157

> PeptideScanner retained ClinicalTrials.gov record NCT02055157 at 2026-07-30T20:07:13.490Z. Its registry update date was 2021-01-15, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct02055157-vosoritide:v1`
- Evidence domain: Clinical trials
- Date in source: 2021-01-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02055157-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct02055157-vosoritide-v1
- Content SHA-256: `2fab6af82ec7d9866f7ada24ae91326867e95819b6456ff125076543a9def1dc`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT02055157 ([`ctg-observation-nct02055157-2021-01-15-ee8e1aa7b638`](#source-ctg-observation-nct02055157-2021-01-15-ee8e1aa7b638))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02055157 at 2026-07-30T20:07:13.490Z. Its registry update date was 2021-01-15, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct02055157-2021-01-15-ee8e1aa7b638`](#source-ctg-observation-nct02055157-2021-01-15-ee8e1aa7b638))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02055157 at 2026-07-30T20:07:13.490Z. Its registry update date was 2021-01-15, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct02055157-2021-01-15-ee8e1aa7b638`](#source-ctg-observation-nct02055157-2021-01-15-ee8e1aa7b638))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02055157-2021-01-15-ee8e1aa7b638`](#source-ctg-observation-nct02055157-2021-01-15-ee8e1aa7b638))

### Sources

<a id="source-ctg-observation-nct02055157-2021-01-15-ee8e1aa7b638"></a>
- **ClinicalTrials.gov record NCT02055157 · retained source version 2021-01-15:ee8e1aa7b638696c40cc294102e24567389735dec46c565026b0693cacfb1918** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02055157) (`ctg-observation-nct02055157-2021-01-15-ee8e1aa7b638`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02055157." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct02055157-vosoritide-v1 SHA-256: 2fab6af82ec7d9866f7ada24ae91326867e95819b6456ff125076543a9def1dc.

---

<a id="clinicaltrials-gov-nct02724228-vosoritide-v1"></a>

## ClinicalTrials.gov record NCT02724228

> PeptideScanner retained ClinicalTrials.gov record NCT02724228 at 2026-07-30T16:22:22.336Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct02724228-vosoritide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02724228-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct02724228-vosoritide-v1
- Content SHA-256: `96ac50c5ae6f7db58baa80d4d56438ecc5ef4f28a5e70160eb6cd3e16416f604`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT02724228 ([`ctg-observation-nct02724228-2026-03-13-befacab35e3b`](#source-ctg-observation-nct02724228-2026-03-13-befacab35e3b))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02724228 at 2026-07-30T16:22:22.336Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct02724228-2026-03-13-befacab35e3b`](#source-ctg-observation-nct02724228-2026-03-13-befacab35e3b))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02724228 at 2026-07-30T16:22:22.336Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct02724228-2026-03-13-befacab35e3b`](#source-ctg-observation-nct02724228-2026-03-13-befacab35e3b))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02724228-2026-03-13-befacab35e3b`](#source-ctg-observation-nct02724228-2026-03-13-befacab35e3b))

### Sources

<a id="source-ctg-observation-nct02724228-2026-03-13-befacab35e3b"></a>
- **ClinicalTrials.gov record NCT02724228 · retained source version 2026-03-13:befacab35e3be51ab92e572d70b36492d944bc7d7946d431108ee7987f834883** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02724228) (`ctg-observation-nct02724228-2026-03-13-befacab35e3b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02724228." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct02724228-vosoritide-v1 SHA-256: 96ac50c5ae6f7db58baa80d4d56438ecc5ef4f28a5e70160eb6cd3e16416f604.

---

<a id="clinicaltrials-gov-nct03989947-vosoritide-v1"></a>

## ClinicalTrials.gov record NCT03989947

> PeptideScanner retained ClinicalTrials.gov record NCT03989947 at 2026-07-30T16:22:22.327Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct03989947-vosoritide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03989947-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct03989947-vosoritide-v1
- Content SHA-256: `35aad5e6936cfa80f0769fd83f6e7fdfb3481d610477670d944990147d1ea9c9`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT03989947 ([`ctg-observation-nct03989947-2026-03-13-80d53f767be4`](#source-ctg-observation-nct03989947-2026-03-13-80d53f767be4))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03989947 at 2026-07-30T16:22:22.327Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct03989947-2026-03-13-80d53f767be4`](#source-ctg-observation-nct03989947-2026-03-13-80d53f767be4))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03989947 at 2026-07-30T16:22:22.327Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct03989947-2026-03-13-80d53f767be4`](#source-ctg-observation-nct03989947-2026-03-13-80d53f767be4))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03989947-2026-03-13-80d53f767be4`](#source-ctg-observation-nct03989947-2026-03-13-80d53f767be4))

### Sources

<a id="source-ctg-observation-nct03989947-2026-03-13-80d53f767be4"></a>
- **ClinicalTrials.gov record NCT03989947 · retained source version 2026-03-13:80d53f767be44ccc06d3ed2f04af7d91cc94b76fe1a9dd2059f80fa02c0bf93a** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03989947) (`ctg-observation-nct03989947-2026-03-13-80d53f767be4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03989947." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct03989947-vosoritide-v1 SHA-256: 35aad5e6936cfa80f0769fd83f6e7fdfb3481d610477670d944990147d1ea9c9.

---

<a id="clinicaltrials-gov-nct04219007-vosoritide-v1"></a>

## ClinicalTrials.gov record NCT04219007

> PeptideScanner retained ClinicalTrials.gov record NCT04219007 at 2026-07-30T16:22:22.347Z. Its registry update date was 2026-03-18, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct04219007-vosoritide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04219007-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct04219007-vosoritide-v1
- Content SHA-256: `dcc60f0c98282657fd73f0b68ca4f3e1156112b690e40f21844a4de542e9caf5`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT04219007 ([`ctg-observation-nct04219007-2026-03-18-106b0651fc9f`](#source-ctg-observation-nct04219007-2026-03-18-106b0651fc9f))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04219007 at 2026-07-30T16:22:22.347Z. Its registry update date was 2026-03-18, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct04219007-2026-03-18-106b0651fc9f`](#source-ctg-observation-nct04219007-2026-03-18-106b0651fc9f))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04219007 at 2026-07-30T16:22:22.347Z. Its registry update date was 2026-03-18, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct04219007-2026-03-18-106b0651fc9f`](#source-ctg-observation-nct04219007-2026-03-18-106b0651fc9f))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04219007-2026-03-18-106b0651fc9f`](#source-ctg-observation-nct04219007-2026-03-18-106b0651fc9f))

### Sources

<a id="source-ctg-observation-nct04219007-2026-03-18-106b0651fc9f"></a>
- **ClinicalTrials.gov record NCT04219007 · retained source version 2026-03-18:106b0651fc9f5f8dcfaeb7d06ecb5486e5e2a66eecb26008e90e86473bc65f9c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04219007) (`ctg-observation-nct04219007-2026-03-18-106b0651fc9f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04219007." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct04219007-vosoritide-v1 SHA-256: dcc60f0c98282657fd73f0b68ca4f3e1156112b690e40f21844a4de542e9caf5.

---

<a id="clinicaltrials-gov-nct04554940-vosoritide-v1"></a>

## ClinicalTrials.gov record NCT04554940

> PeptideScanner retained ClinicalTrials.gov record NCT04554940 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct04554940-vosoritide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04554940-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct04554940-vosoritide-v1
- Content SHA-256: `204a942611535c8d28d39902026150cde4d9d5d789b97dc9fe19fe030a21997a`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT04554940 ([`ctg-observation-nct04554940-2026-03-13-572bf42dd5bf`](#source-ctg-observation-nct04554940-2026-03-13-572bf42dd5bf))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04554940 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct04554940-2026-03-13-572bf42dd5bf`](#source-ctg-observation-nct04554940-2026-03-13-572bf42dd5bf))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04554940 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct04554940-2026-03-13-572bf42dd5bf`](#source-ctg-observation-nct04554940-2026-03-13-572bf42dd5bf))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04554940-2026-03-13-572bf42dd5bf`](#source-ctg-observation-nct04554940-2026-03-13-572bf42dd5bf))

### Sources

<a id="source-ctg-observation-nct04554940-2026-03-13-572bf42dd5bf"></a>
- **ClinicalTrials.gov record NCT04554940 · retained source version 2026-03-13:572bf42dd5bf732d4533515d7d4c4855d352cda00f531c83b01a83c30085087a** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04554940) (`ctg-observation-nct04554940-2026-03-13-572bf42dd5bf`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04554940." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct04554940-vosoritide-v1 SHA-256: 204a942611535c8d28d39902026150cde4d9d5d789b97dc9fe19fe030a21997a.

---

<a id="clinicaltrials-gov-nct05845749-vosoritide-v1"></a>

## ClinicalTrials.gov record NCT05845749

> PeptideScanner retained ClinicalTrials.gov record NCT05845749 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct05845749-vosoritide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05845749-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct05845749-vosoritide-v1
- Content SHA-256: `2ce5972b4fa766222fe66835acf37b93707a9d4b62ab6d6dec1d94f5594ddc67`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05845749 ([`ctg-observation-nct05845749-2026-03-10-44c431af1724`](#source-ctg-observation-nct05845749-2026-03-10-44c431af1724))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05845749 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct05845749-2026-03-10-44c431af1724`](#source-ctg-observation-nct05845749-2026-03-10-44c431af1724))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05845749 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct05845749-2026-03-10-44c431af1724`](#source-ctg-observation-nct05845749-2026-03-10-44c431af1724))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05845749-2026-03-10-44c431af1724`](#source-ctg-observation-nct05845749-2026-03-10-44c431af1724))

### Sources

<a id="source-ctg-observation-nct05845749-2026-03-10-44c431af1724"></a>
- **ClinicalTrials.gov record NCT05845749 · retained source version 2026-03-10:44c431af17249d0c6ab44ea2311d816edfaec20ccfe4e9a084e561b2e5fc4a07** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05845749) (`ctg-observation-nct05845749-2026-03-10-44c431af1724`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05845749." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct05845749-vosoritide-v1 SHA-256: 2ce5972b4fa766222fe66835acf37b93707a9d4b62ab6d6dec1d94f5594ddc67.

---

<a id="clinicaltrials-gov-nct05849389-vosoritide-v1"></a>

## ClinicalTrials.gov record NCT05849389

> PeptideScanner retained ClinicalTrials.gov record NCT05849389 at 2026-07-30T18:43:56.187Z. Its registry update date was 2024-06-24, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct05849389-vosoritide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-06-24
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05849389-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct05849389-vosoritide-v1
- Content SHA-256: `01c18172f75a785038bf6694c440d407ed57f8dea2f1cd90be3b5fa97e084fbb`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05849389 ([`ctg-observation-nct05849389-2024-06-24-c71158251c5f`](#source-ctg-observation-nct05849389-2024-06-24-c71158251c5f))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05849389 at 2026-07-30T18:43:56.187Z. Its registry update date was 2024-06-24, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct05849389-2024-06-24-c71158251c5f`](#source-ctg-observation-nct05849389-2024-06-24-c71158251c5f))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05849389 at 2026-07-30T18:43:56.187Z. Its registry update date was 2024-06-24, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct05849389-2024-06-24-c71158251c5f`](#source-ctg-observation-nct05849389-2024-06-24-c71158251c5f))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05849389-2024-06-24-c71158251c5f`](#source-ctg-observation-nct05849389-2024-06-24-c71158251c5f))

### Sources

<a id="source-ctg-observation-nct05849389-2024-06-24-c71158251c5f"></a>
- **ClinicalTrials.gov record NCT05849389 · retained source version 2024-06-24:c71158251c5f35f7858c58f7976e2fc28615c5aba60d65250e5d6761a4caac71** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05849389) (`ctg-observation-nct05849389-2024-06-24-c71158251c5f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05849389." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct05849389-vosoritide-v1 SHA-256: 01c18172f75a785038bf6694c440d407ed57f8dea2f1cd90be3b5fa97e084fbb.

---

<a id="clinicaltrials-gov-nct06455059-vosoritide-v1"></a>

## ClinicalTrials.gov record NCT06455059

> PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-20, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct06455059-vosoritide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-01-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06455059-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct06455059-vosoritide-v1
- Content SHA-256: `8153a037756da29909d601ee4197e0f76678fcd9948475e4acf4579ea4996dca`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06455059 ([`ctg-observation-nct06455059-2026-01-20-bc7bbe888685`](#source-ctg-observation-nct06455059-2026-01-20-bc7bbe888685))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-20, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct06455059-2026-01-20-bc7bbe888685`](#source-ctg-observation-nct06455059-2026-01-20-bc7bbe888685))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-20, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct06455059-2026-01-20-bc7bbe888685`](#source-ctg-observation-nct06455059-2026-01-20-bc7bbe888685))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06455059-2026-01-20-bc7bbe888685`](#source-ctg-observation-nct06455059-2026-01-20-bc7bbe888685))

### Sources

<a id="source-ctg-observation-nct06455059-2026-01-20-bc7bbe888685"></a>
- **ClinicalTrials.gov record NCT06455059 · retained source version 2026-01-20:bc7bbe8886856e8a08acfab6752e5d6fe5100ba04b9de2d2c2fe345176c296a0** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06455059) (`ctg-observation-nct06455059-2026-01-20-bc7bbe888685`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06455059." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct06455059-vosoritide-v1 SHA-256: 8153a037756da29909d601ee4197e0f76678fcd9948475e4acf4579ea4996dca.

---

<a id="clinicaltrials-gov-nct06455059-vosoritide-v2"></a>

## ClinicalTrials.gov record NCT06455059

> PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct06455059-vosoritide:v2`
- Evidence domain: Clinical trials
- Date in source: 2026-11-12
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06455059-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct06455059-vosoritide-v2
- Content SHA-256: `dc21bc0252c5083c569b98763e08f4b89c1f87745a370feb334df5e31530b3f0`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06455059 ([`ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2`](#source-ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2`](#source-ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2`](#source-ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2`](#source-ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2))

### Sources

<a id="source-ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2"></a>
- **ClinicalTrials.gov record NCT06455059 · retained source version 2026-11-12:36320579eb084c07cd5c7fa545d2978dfce5033ea3767498ec111b361b735fe5** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06455059) (`ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2`)

### Correction lineage

updated on 2026-11-15: ClinicalTrials.gov posted a newer version of NCT06455059, with a registry update date of 2026-11-12. This version reports that observation; the earlier retained observation remains available as version 1.
- Supersedes version: 1
- Correction sources: [`ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2`](#source-ctg-observation-nct06455059-2026-01-20-bc7bbe888685-r2)

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06455059." Version 2, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct06455059-vosoritide-v2 SHA-256: dc21bc0252c5083c569b98763e08f4b89c1f87745a370feb334df5e31530b3f0.

---

<a id="clinicaltrials-gov-nct07073014-vosoritide-v1"></a>

## ClinicalTrials.gov record NCT07073014

> PeptideScanner retained ClinicalTrials.gov record NCT07073014 at 2026-07-30T18:24:37.179Z. Its registry update date was 2025-07-18, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct07073014-vosoritide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-07-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07073014-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct07073014-vosoritide-v1
- Content SHA-256: `a0fe03da5b137ed5a65dda39eadb5f9023a6b0c83ef77112c357d209b29c64bb`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07073014 ([`ctg-observation-nct07073014-2025-07-18-b360817cd28e`](#source-ctg-observation-nct07073014-2025-07-18-b360817cd28e))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07073014 at 2026-07-30T18:24:37.179Z. Its registry update date was 2025-07-18, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct07073014-2025-07-18-b360817cd28e`](#source-ctg-observation-nct07073014-2025-07-18-b360817cd28e))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07073014 at 2026-07-30T18:24:37.179Z. Its registry update date was 2025-07-18, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct07073014-2025-07-18-b360817cd28e`](#source-ctg-observation-nct07073014-2025-07-18-b360817cd28e))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07073014-2025-07-18-b360817cd28e`](#source-ctg-observation-nct07073014-2025-07-18-b360817cd28e))

### Sources

<a id="source-ctg-observation-nct07073014-2025-07-18-b360817cd28e"></a>
- **ClinicalTrials.gov record NCT07073014 · retained source version 2025-07-18:b360817cd28e397038dee4c2e7b43c6420465c13ea7c308afa7d5666ca7932a1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07073014) (`ctg-observation-nct07073014-2025-07-18-b360817cd28e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07073014." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct07073014-vosoritide-v1 SHA-256: a0fe03da5b137ed5a65dda39eadb5f9023a6b0c83ef77112c357d209b29c64bb.

---

<a id="clinicaltrials-gov-nct07126262-vosoritide-v1"></a>

## ClinicalTrials.gov record NCT07126262

> PeptideScanner retained ClinicalTrials.gov record NCT07126262 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct07126262-vosoritide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-31
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07126262-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct07126262-vosoritide-v1
- Content SHA-256: `72b7efcda19feb1f6234f34a34b76d4d9dcac2994c3546675778ba17948693b7`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07126262 ([`ctg-observation-nct07126262-2026-03-31-59cc92529aa2`](#source-ctg-observation-nct07126262-2026-03-31-59cc92529aa2))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07126262 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct07126262-2026-03-31-59cc92529aa2`](#source-ctg-observation-nct07126262-2026-03-31-59cc92529aa2))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07126262 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct07126262-2026-03-31-59cc92529aa2`](#source-ctg-observation-nct07126262-2026-03-31-59cc92529aa2))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07126262-2026-03-31-59cc92529aa2`](#source-ctg-observation-nct07126262-2026-03-31-59cc92529aa2))

### Sources

<a id="source-ctg-observation-nct07126262-2026-03-31-59cc92529aa2"></a>
- **ClinicalTrials.gov record NCT07126262 · retained source version 2026-03-31:59cc92529aa25cb18fed915511938f7e6c0bcba05e118d5efec5f8dfd3688e05** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07126262) (`ctg-observation-nct07126262-2026-03-31-59cc92529aa2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07126262." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#clinicaltrials-gov-nct07126262-vosoritide-v1 SHA-256: 72b7efcda19feb1f6234f34a34b76d4d9dcac2994c3546675778ba17948693b7.

---

<a id="dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-v1"></a>

## Vosoritide DailyMed SPL version 10

> DailyMed lists Structured Product Labeling version 10 for the reviewed Vosoritide label family with a published date of 2023-11-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10:v1`
- Evidence domain: Regulatory
- Date in source: 2023-11-15
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-v1
- Content SHA-256: `89748171723dd85b9bfdc7d6bb88f832e6979c47da10c29d92077fa857523e3b`

### Claims and source pins

#### Headline

Vosoritide DailyMed SPL version 10 ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-history))

#### Summary

DailyMed lists Structured Product Labeling version 10 for the reviewed Vosoritide label family with a published date of 2023-11-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 10 for the reviewed Vosoritide label family with a published date of 2023-11-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-history))

### Sources

<a id="source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-history"></a>
- **DailyMed SPL SET ID 228e8560-04a4-4bb1-a81f-29531a9e4d27 · SPL version 10 · published 2023-11-15 · retained ZIP SHA-256 d6c62a5e2b00a0b56dd15b1ac2eb6917f51379f3f5b227a640f51bd77f0ca502** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=228e8560-04a4-4bb1-a81f-29531a9e4d27&version=10) (`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide DailyMed SPL version 10." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v10-v1 SHA-256: 89748171723dd85b9bfdc7d6bb88f832e6979c47da10c29d92077fa857523e3b.

---

<a id="dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-v1"></a>

## Vosoritide DailyMed SPL version 11

> DailyMed lists Structured Product Labeling version 11 for the reviewed Vosoritide label family with a published date of 2024-04-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11:v1`
- Evidence domain: Regulatory
- Date in source: 2024-04-12
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-v1
- Content SHA-256: `b9d873dae9c7b3a80586bbc68244720e43556cc0e6cf61abb4c941464bdfc6ec`

### Claims and source pins

#### Headline

Vosoritide DailyMed SPL version 11 ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-history))

#### Summary

DailyMed lists Structured Product Labeling version 11 for the reviewed Vosoritide label family with a published date of 2024-04-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 11 for the reviewed Vosoritide label family with a published date of 2024-04-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-history))

### Sources

<a id="source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-history"></a>
- **DailyMed SPL SET ID 228e8560-04a4-4bb1-a81f-29531a9e4d27 · SPL version 11 · published 2024-04-12 · retained ZIP SHA-256 be8f9c1d8d00f1be4c30e4ff1a2b1faa3a6fbcc867e0c9413d9505b999b55d35** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=228e8560-04a4-4bb1-a81f-29531a9e4d27&version=11) (`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide DailyMed SPL version 11." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v11-v1 SHA-256: b9d873dae9c7b3a80586bbc68244720e43556cc0e6cf61abb4c941464bdfc6ec.

---

<a id="dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-v1"></a>

## Vosoritide DailyMed SPL version 12

> DailyMed lists Structured Product Labeling version 12 for the reviewed Vosoritide label family with a published date of 2024-04-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12:v1`
- Evidence domain: Regulatory
- Date in source: 2024-04-15
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-v1
- Content SHA-256: `eb8c8868785d3aa9254721a6f8d75b7966b115128028a9f20a216d6fbf1a1387`

### Claims and source pins

#### Headline

Vosoritide DailyMed SPL version 12 ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-history))

#### Summary

DailyMed lists Structured Product Labeling version 12 for the reviewed Vosoritide label family with a published date of 2024-04-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 12 for the reviewed Vosoritide label family with a published date of 2024-04-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-history))

### Sources

<a id="source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-history"></a>
- **DailyMed SPL SET ID 228e8560-04a4-4bb1-a81f-29531a9e4d27 · SPL version 12 · published 2024-04-15 · retained ZIP SHA-256 d005e7bc5ddcdf9df6b1ecc14eb4fd22aaec38b298b5d2aa9bd9d2d335a93d01** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=228e8560-04a4-4bb1-a81f-29531a9e4d27&version=12) (`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide DailyMed SPL version 12." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v12-v1 SHA-256: eb8c8868785d3aa9254721a6f8d75b7966b115128028a9f20a216d6fbf1a1387.

---

<a id="dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-v1"></a>

## Vosoritide DailyMed SPL version 14

> DailyMed lists Structured Product Labeling version 14 for the reviewed Vosoritide label family with a published date of 2024-11-13. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14:v1`
- Evidence domain: Regulatory
- Date in source: 2024-11-13
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-v1
- Content SHA-256: `1143263b438107a10e7505a0b96cd393e926a92fe6c3e9e026f59e97df4e37b4`

### Claims and source pins

#### Headline

Vosoritide DailyMed SPL version 14 ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-history))

#### Summary

DailyMed lists Structured Product Labeling version 14 for the reviewed Vosoritide label family with a published date of 2024-11-13. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 14 for the reviewed Vosoritide label family with a published date of 2024-11-13. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-history))

### Sources

<a id="source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-history"></a>
- **DailyMed SPL SET ID 228e8560-04a4-4bb1-a81f-29531a9e4d27 · SPL version 14 · published 2024-11-13 · retained ZIP SHA-256 d307e9e4a58e8e324c87140961cabde30a126eba48f4e90296938e966d6ad758** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=228e8560-04a4-4bb1-a81f-29531a9e4d27&version=14) (`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide DailyMed SPL version 14." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v14-v1 SHA-256: 1143263b438107a10e7505a0b96cd393e926a92fe6c3e9e026f59e97df4e37b4.

---

<a id="dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-v1"></a>

## Vosoritide DailyMed SPL version 15

> DailyMed lists Structured Product Labeling version 15 for the reviewed Vosoritide label family with a published date of 2024-12-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15:v1`
- Evidence domain: Regulatory
- Date in source: 2024-12-20
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-v1
- Content SHA-256: `e7779b74d9f5b299a7276493d51589e39037c65ec07ed16f0547166626f04e4c`

### Claims and source pins

#### Headline

Vosoritide DailyMed SPL version 15 ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-history))

#### Summary

DailyMed lists Structured Product Labeling version 15 for the reviewed Vosoritide label family with a published date of 2024-12-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 15 for the reviewed Vosoritide label family with a published date of 2024-12-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-history))

### Sources

<a id="source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-history"></a>
- **DailyMed SPL SET ID 228e8560-04a4-4bb1-a81f-29531a9e4d27 · SPL version 15 · published 2024-12-20 · retained ZIP SHA-256 67c91f5448156134f7b3d8cd663c0edc108824476d260ecede72ec3f48ec6c2c** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=228e8560-04a4-4bb1-a81f-29531a9e4d27&version=15) (`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide DailyMed SPL version 15." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v15-v1 SHA-256: e7779b74d9f5b299a7276493d51589e39037c65ec07ed16f0547166626f04e4c.

---

<a id="dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-v1"></a>

## Vosoritide DailyMed SPL version 16

> DailyMed lists Structured Product Labeling version 16 for the reviewed Vosoritide label family with a published date of 2025-11-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16:v1`
- Evidence domain: Regulatory
- Date in source: 2025-11-26
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-v1
- Content SHA-256: `2bfed2647dda135231c663d70e38ea323b22615308669ccadfe799bd8b3b1570`

### Claims and source pins

#### Headline

Vosoritide DailyMed SPL version 16 ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-history))

#### Summary

DailyMed lists Structured Product Labeling version 16 for the reviewed Vosoritide label family with a published date of 2025-11-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 16 for the reviewed Vosoritide label family with a published date of 2025-11-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-history))

### Sources

<a id="source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-history"></a>
- **DailyMed SPL SET ID 228e8560-04a4-4bb1-a81f-29531a9e4d27 · SPL version 16 · published 2025-11-26 · retained ZIP SHA-256 01bd93709f678ebf940f87c036fa3fe74fef3e457891d243c5c4e759d0253924** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=228e8560-04a4-4bb1-a81f-29531a9e4d27&version=16) (`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide DailyMed SPL version 16." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16-v1 SHA-256: 2bfed2647dda135231c663d70e38ea323b22615308669ccadfe799bd8b3b1570.

---

<a id="dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-v1"></a>

## Vosoritide DailyMed SPL version 8

> DailyMed lists Structured Product Labeling version 8 for the reviewed Vosoritide label family with a published date of 2021-12-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8:v1`
- Evidence domain: Regulatory
- Date in source: 2021-12-03
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-v1
- Content SHA-256: `5408081dee2684baeee014792f0781871f8d3d25ee2ec129f8b437b34985f6bd`

### Claims and source pins

#### Headline

Vosoritide DailyMed SPL version 8 ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-history))

#### Summary

DailyMed lists Structured Product Labeling version 8 for the reviewed Vosoritide label family with a published date of 2021-12-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 8 for the reviewed Vosoritide label family with a published date of 2021-12-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-history`](#source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-history))

### Sources

<a id="source-dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-history"></a>
- **DailyMed SPL SET ID 228e8560-04a4-4bb1-a81f-29531a9e4d27 · SPL version 8 · published 2021-12-03 · retained ZIP SHA-256 766c98927d943e8c92e93901f0cda41bd353b73300ee2cff1c09bc81a9a615b4** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=228e8560-04a4-4bb1-a81f-29531a9e4d27&version=8) (`dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide DailyMed SPL version 8." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#dailymed-label-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v8-v1 SHA-256: 5408081dee2684baeee014792f0781871f8d3d25ee2ec129f8b437b34985f6bd.

---

<a id="fda-drugs-nda214938-v1"></a>

## Drugs@FDA application NDA214938

> The official Drugs@FDA dataset lists original submission 1 for NDA 214938 with status AP dated 2021-11-19, and names vosoritide among the application record's active ingredients.

- Evidence object: `story:fda-drugs-nda214938:v1`
- Evidence domain: Regulatory
- Date in source: 2021-11-19
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/fda-drugs-nda214938/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#fda-drugs-nda214938-v1
- Content SHA-256: `4059787c4f295325c1364609200f9bd35c54753a3e8348b3244698c8bd056f77`

### Claims and source pins

#### Headline

Drugs@FDA application NDA214938 ([`fda-drugs-nda214938-2021-11-19-6bf5863742a4`](#source-fda-drugs-nda214938-2021-11-19-6bf5863742a4))

#### Summary

The official Drugs@FDA dataset lists original submission 1 for NDA 214938 with status AP dated 2021-11-19, and names vosoritide among the application record's active ingredients. ([`fda-drugs-nda214938-2021-11-19-6bf5863742a4`](#source-fda-drugs-nda214938-2021-11-19-6bf5863742a4))

#### Paragraph 1

The official Drugs@FDA dataset lists original submission 1 for NDA 214938 with status AP dated 2021-11-19, and names vosoritide among the application record's active ingredients. ([`fda-drugs-nda214938-2021-11-19-6bf5863742a4`](#source-fda-drugs-nda214938-2021-11-19-6bf5863742a4))

#### Paragraph 2

This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance. ([`fda-drugs-nda214938-2021-11-19-6bf5863742a4`](#source-fda-drugs-nda214938-2021-11-19-6bf5863742a4))

### Sources

<a id="source-fda-drugs-nda214938-2021-11-19-6bf5863742a4"></a>
- **Drugs@FDA application NDA214938 · original submission status AP · 2021-11-19 · dataset 2026-08-13** — Drugs@FDA via openFDA; class A. [Open source](https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA214938%22&limit=1) (`fda-drugs-nda214938-2021-11-19-6bf5863742a4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Drugs@FDA application NDA214938." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#fda-drugs-nda214938-v1 SHA-256: 4059787c4f295325c1364609200f9bd35c54753a3e8348b3244698c8bd056f77.

---

<a id="federal-register-2022-19155-v1"></a>

## Federal Register notice 2022-19155

> The Federal Register published notice 2022-19155, attributed to FDA and its parent HHS department, on 2022-09-06. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product,” and PeptideScanner's exact reviewed identity mapping connects the document to Vosoritide.

- Evidence object: `story:federal-register-2022-19155:v1`
- Evidence domain: Regulatory
- Date in source: 2022-09-06
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-2022-19155/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#federal-register-2022-19155-v1
- Content SHA-256: `b74c6596e3077f6c64369ec302c1c25ba9a0e2f52de0094f7e7987026ae55570`

### Claims and source pins

#### Headline

Federal Register notice 2022-19155 ([`federal-register-2022-19155-10adafc85e4f`](#source-federal-register-2022-19155-10adafc85e4f))

#### Summary

The Federal Register published notice 2022-19155, attributed to FDA and its parent HHS department, on 2022-09-06. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product,” and PeptideScanner's exact reviewed identity mapping connects the document to Vosoritide. ([`federal-register-2022-19155-10adafc85e4f`](#source-federal-register-2022-19155-10adafc85e4f))

#### Paragraph 1

The Federal Register published notice 2022-19155, attributed to FDA and its parent HHS department, on 2022-09-06. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product,” and PeptideScanner's exact reviewed identity mapping connects the document to Vosoritide. ([`federal-register-2022-19155-10adafc85e4f`](#source-federal-register-2022-19155-10adafc85e4f))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-2022-19155-10adafc85e4f`](#source-federal-register-2022-19155-10adafc85e4f))

### Sources

<a id="source-federal-register-2022-19155-10adafc85e4f"></a>
- **Federal Register notice 2022-19155 · published 2022-09-06 · Issuance of Priority Review Voucher; Rare Pediatric Disease Product** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2022-09-06/pdf/2022-19155.pdf) (`federal-register-2022-19155-10adafc85e4f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice 2022-19155." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#federal-register-2022-19155-v1 SHA-256: b74c6596e3077f6c64369ec302c1c25ba9a0e2f52de0094f7e7987026ae55570.

---

<a id="federal-register-2024-04479-v1"></a>

## Federal Register notice 2024-04479

> The Federal Register published notice 2024-04479, attributed to FDA and its parent HHS department, on 2024-03-04. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; VOXZOGO,” and PeptideScanner's exact reviewed identity mapping connects the document to Vosoritide.

- Evidence object: `story:federal-register-2024-04479:v1`
- Evidence domain: Regulatory
- Date in source: 2024-03-04
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-2024-04479/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#federal-register-2024-04479-v1
- Content SHA-256: `0347a8d1db0741ef52edab726ef27a81a888aa6d517921e50583ab95c59d9a62`

### Claims and source pins

#### Headline

Federal Register notice 2024-04479 ([`federal-register-2024-04479-6f5ca1778593`](#source-federal-register-2024-04479-6f5ca1778593))

#### Summary

The Federal Register published notice 2024-04479, attributed to FDA and its parent HHS department, on 2024-03-04. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; VOXZOGO,” and PeptideScanner's exact reviewed identity mapping connects the document to Vosoritide. ([`federal-register-2024-04479-6f5ca1778593`](#source-federal-register-2024-04479-6f5ca1778593))

#### Paragraph 1

The Federal Register published notice 2024-04479, attributed to FDA and its parent HHS department, on 2024-03-04. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; VOXZOGO,” and PeptideScanner's exact reviewed identity mapping connects the document to Vosoritide. ([`federal-register-2024-04479-6f5ca1778593`](#source-federal-register-2024-04479-6f5ca1778593))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-2024-04479-6f5ca1778593`](#source-federal-register-2024-04479-6f5ca1778593))

### Sources

<a id="source-federal-register-2024-04479-6f5ca1778593"></a>
- **Federal Register notice 2024-04479 · published 2024-03-04 · Determination of Regulatory Review Period for Purposes of Patent Extension; VOXZOGO** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2024-03-04/pdf/2024-04479.pdf) (`federal-register-2024-04479-6f5ca1778593`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice 2024-04479." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#federal-register-2024-04479-v1 SHA-256: 0347a8d1db0741ef52edab726ef27a81a888aa6d517921e50583ab95c59d9a62.

---

<a id="pubmed-pmid-34694597-vosoritide-v1"></a>

## Vosoritide: First Approval.

> PubMed lists PMID 34694597 in Drugs as Journal Article, Review, with publication-date metadata of 2021-11 (month precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-34694597-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-02-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-34694597-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-34694597-vosoritide-v1
- Content SHA-256: `8b3763e03403b1e9608986a232fcbc5432a2793999958d561a0c4211ec17ad20`

### Claims and source pins

#### Headline

Vosoritide: First Approval. ([`pubmed-observation-pmid-34694597-2022-02-14-9c85d601ee77`](#source-pubmed-observation-pmid-34694597-2022-02-14-9c85d601ee77))

#### Summary

PubMed lists PMID 34694597 in Drugs as Journal Article, Review, with publication-date metadata of 2021-11 (month precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34694597-2022-02-14-9c85d601ee77`](#source-pubmed-observation-pmid-34694597-2022-02-14-9c85d601ee77))

#### Paragraph 1

PubMed lists PMID 34694597 in Drugs as Journal Article, Review, with publication-date metadata of 2021-11 (month precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34694597-2022-02-14-9c85d601ee77`](#source-pubmed-observation-pmid-34694597-2022-02-14-9c85d601ee77))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-34694597-2022-02-14-9c85d601ee77`](#source-pubmed-observation-pmid-34694597-2022-02-14-9c85d601ee77))

### Sources

<a id="source-pubmed-observation-pmid-34694597-2022-02-14-9c85d601ee77"></a>
- **Vosoritide: First Approval. · retained source version 1:2022-02-14:current:9c85d601ee773d20870cbc92fb473185a4051d91a658c2d407a1fb87604a349d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/34694597/) (`pubmed-observation-pmid-34694597-2022-02-14-9c85d601ee77`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide: First Approval." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-34694597-vosoritide-v1 SHA-256: 8b3763e03403b1e9608986a232fcbc5432a2793999958d561a0c4211ec17ad20.

---

<a id="pubmed-pmid-35180295-vosoritide-v1"></a>

## Vosoritide.

> PubMed lists PMID 35180295 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2022-03-07 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-35180295-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-03-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-35180295-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-35180295-vosoritide-v1
- Content SHA-256: `04089b21ecc50401e0bb9275d435b9640402cb42555867475f44f0e6c9a5f006`

### Claims and source pins

#### Headline

Vosoritide. ([`pubmed-observation-pmid-35180295-2022-03-16-f1d4c7428c10`](#source-pubmed-observation-pmid-35180295-2022-03-16-f1d4c7428c10))

#### Summary

PubMed lists PMID 35180295 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2022-03-07 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35180295-2022-03-16-f1d4c7428c10`](#source-pubmed-observation-pmid-35180295-2022-03-16-f1d4c7428c10))

#### Paragraph 1

PubMed lists PMID 35180295 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2022-03-07 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35180295-2022-03-16-f1d4c7428c10`](#source-pubmed-observation-pmid-35180295-2022-03-16-f1d4c7428c10))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-35180295-2022-03-16-f1d4c7428c10`](#source-pubmed-observation-pmid-35180295-2022-03-16-f1d4c7428c10))

### Sources

<a id="source-pubmed-observation-pmid-35180295-2022-03-16-f1d4c7428c10"></a>
- **Vosoritide. · retained source version 1:2022-03-16:current:f1d4c7428c10cd2a686971423f41d8f0d756f3ea86e8a0cf68f0b0e2f381212f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/35180295/) (`pubmed-observation-pmid-35180295-2022-03-16-f1d4c7428c10`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-35180295-vosoritide-v1 SHA-256: 04089b21ecc50401e0bb9275d435b9640402cb42555867475f44f0e6c9a5f006.

---

<a id="pubmed-pmid-38649657-vosoritide-v1"></a>

## PubMed record PMID 38649657

> PeptideScanner retained PubMed bibliographic metadata for PMID 38649657 at 2026-08-10T18:13:32.355Z. PubMed recorded a metadata revision date of 2026-07-02 and an Entrez history date of 2024-04-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-38649657-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-02
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38649657-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-38649657-vosoritide-v1
- Content SHA-256: `cd5c88326c2683747a0568f5c653d1871fdc30d51f80537f340ccb771a701b65`

### Claims and source pins

#### Headline

PubMed record PMID 38649657 ([`pubmed-observation-pmid-38649657-2026-07-02-ae02b0ca6612`](#source-pubmed-observation-pmid-38649657-2026-07-02-ae02b0ca6612))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 38649657 at 2026-08-10T18:13:32.355Z. PubMed recorded a metadata revision date of 2026-07-02 and an Entrez history date of 2024-04-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38649657-2026-07-02-ae02b0ca6612`](#source-pubmed-observation-pmid-38649657-2026-07-02-ae02b0ca6612))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 38649657 at 2026-08-10T18:13:32.355Z. PubMed recorded a metadata revision date of 2026-07-02 and an Entrez history date of 2024-04-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38649657-2026-07-02-ae02b0ca6612`](#source-pubmed-observation-pmid-38649657-2026-07-02-ae02b0ca6612))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38649657-2026-07-02-ae02b0ca6612`](#source-pubmed-observation-pmid-38649657-2026-07-02-ae02b0ca6612))

### Sources

<a id="source-pubmed-observation-pmid-38649657-2026-07-02-ae02b0ca6612"></a>
- **PubMed record PMID 38649657 · retained source version 1:2026-07-02:current:ae02b0ca66122aa75d5abdaf41fa428c95f70d1dc4d5d5483391596db95432d4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38649657/) (`pubmed-observation-pmid-38649657-2026-07-02-ae02b0ca6612`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 38649657." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-38649657-vosoritide-v1 SHA-256: cd5c88326c2683747a0568f5c653d1871fdc30d51f80537f340ccb771a701b65.

---

<a id="pubmed-pmid-38813446-vosoritide-v1"></a>

## Vosoritide treatment for children with hypochondroplasia: a phase 2 trial.

> PubMed lists PMID 38813446 in EClinicalMedicine as Journal Article, with publication-date metadata of 2024-04-11 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38813446-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-05-31
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38813446-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-38813446-vosoritide-v1
- Content SHA-256: `c77968fa4394fc330f24b0984194660fbad2d10a7e043b59cc175bb2f5a0a94d`

### Claims and source pins

#### Headline

Vosoritide treatment for children with hypochondroplasia: a phase 2 trial. ([`pubmed-observation-pmid-38813446-2024-05-31-6d8eb2173353`](#source-pubmed-observation-pmid-38813446-2024-05-31-6d8eb2173353))

#### Summary

PubMed lists PMID 38813446 in EClinicalMedicine as Journal Article, with publication-date metadata of 2024-04-11 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38813446-2024-05-31-6d8eb2173353`](#source-pubmed-observation-pmid-38813446-2024-05-31-6d8eb2173353))

#### Paragraph 1

PubMed lists PMID 38813446 in EClinicalMedicine as Journal Article, with publication-date metadata of 2024-04-11 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38813446-2024-05-31-6d8eb2173353`](#source-pubmed-observation-pmid-38813446-2024-05-31-6d8eb2173353))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38813446-2024-05-31-6d8eb2173353`](#source-pubmed-observation-pmid-38813446-2024-05-31-6d8eb2173353))

### Sources

<a id="source-pubmed-observation-pmid-38813446-2024-05-31-6d8eb2173353"></a>
- **Vosoritide treatment for children with hypochondroplasia: a phase 2 trial. · retained source version 1:2024-05-31:current:6d8eb21733536154b2fbd0b03f996b9f94417823e884956e818fd1610cc6f852** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38813446/) (`pubmed-observation-pmid-38813446-2024-05-31-6d8eb2173353`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide treatment for children with hypochondroplasia: a phase 2 trial." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-38813446-vosoritide-v1 SHA-256: c77968fa4394fc330f24b0984194660fbad2d10a7e043b59cc175bb2f5a0a94d.

---

<a id="pubmed-pmid-39062238-vosoritide-v1"></a>

## Consensus Guidelines for the Use of Vosoritide in Children with Achondroplasia in Australia.

> PubMed lists PMID 39062238 in Children (Basel, Switzerland) as Journal Article, with publication-date metadata of 2024-06-28 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39062238-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-07-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39062238-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-39062238-vosoritide-v1
- Content SHA-256: `2e29d7ed24e291de514f0df390e431fbd4720bfe7a7e737ff080b5f69b328bfb`

### Claims and source pins

#### Headline

Consensus Guidelines for the Use of Vosoritide in Children with Achondroplasia in Australia. ([`pubmed-observation-pmid-39062238-2024-07-29-fbf69723d51b`](#source-pubmed-observation-pmid-39062238-2024-07-29-fbf69723d51b))

#### Summary

PubMed lists PMID 39062238 in Children (Basel, Switzerland) as Journal Article, with publication-date metadata of 2024-06-28 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39062238-2024-07-29-fbf69723d51b`](#source-pubmed-observation-pmid-39062238-2024-07-29-fbf69723d51b))

#### Paragraph 1

PubMed lists PMID 39062238 in Children (Basel, Switzerland) as Journal Article, with publication-date metadata of 2024-06-28 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39062238-2024-07-29-fbf69723d51b`](#source-pubmed-observation-pmid-39062238-2024-07-29-fbf69723d51b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39062238-2024-07-29-fbf69723d51b`](#source-pubmed-observation-pmid-39062238-2024-07-29-fbf69723d51b))

### Sources

<a id="source-pubmed-observation-pmid-39062238-2024-07-29-fbf69723d51b"></a>
- **Consensus Guidelines for the Use of Vosoritide in Children with Achondroplasia in Australia. · retained source version 1:2024-07-29:current:fbf69723d51b93112877d253f8aae12790eb06b499f879739d6cefd533399615** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39062238/) (`pubmed-observation-pmid-39062238-2024-07-29-fbf69723d51b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Consensus Guidelines for the Use of Vosoritide in Children with Achondroplasia in Australia." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-39062238-vosoritide-v1 SHA-256: 2e29d7ed24e291de514f0df390e431fbd4720bfe7a7e737ff080b5f69b328bfb.

---

<a id="pubmed-pmid-39289684-vosoritide-v1"></a>

## PubMed record PMID 39289684

> PeptideScanner retained PubMed bibliographic metadata for PMID 39289684 at 2026-07-30T16:20:39.015Z. PubMed recorded a metadata revision date of 2026-05-19 and an Entrez history date of 2024-09-17. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-39289684-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39289684-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-39289684-vosoritide-v1
- Content SHA-256: `eb6bdffa5c2ee45a55408831a0d00cb73752a207d90714a79f5d70ffd4430a6c`

### Claims and source pins

#### Headline

PubMed record PMID 39289684 ([`pubmed-observation-pmid-39289684-2026-05-19-80ee48f71bb8`](#source-pubmed-observation-pmid-39289684-2026-05-19-80ee48f71bb8))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 39289684 at 2026-07-30T16:20:39.015Z. PubMed recorded a metadata revision date of 2026-05-19 and an Entrez history date of 2024-09-17. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39289684-2026-05-19-80ee48f71bb8`](#source-pubmed-observation-pmid-39289684-2026-05-19-80ee48f71bb8))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 39289684 at 2026-07-30T16:20:39.015Z. PubMed recorded a metadata revision date of 2026-05-19 and an Entrez history date of 2024-09-17. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39289684-2026-05-19-80ee48f71bb8`](#source-pubmed-observation-pmid-39289684-2026-05-19-80ee48f71bb8))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39289684-2026-05-19-80ee48f71bb8`](#source-pubmed-observation-pmid-39289684-2026-05-19-80ee48f71bb8))

### Sources

<a id="source-pubmed-observation-pmid-39289684-2026-05-19-80ee48f71bb8"></a>
- **PubMed record PMID 39289684 · retained source version 1:2026-05-19:current:80ee48f71bb8f1e73a1a9a998d92f81e25f96c31a479b2de7d28c5094fa2df0a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39289684/) (`pubmed-observation-pmid-39289684-2026-05-19-80ee48f71bb8`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 39289684." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-39289684-vosoritide-v1 SHA-256: eb6bdffa5c2ee45a55408831a0d00cb73752a207d90714a79f5d70ffd4430a6c.

---

<a id="pubmed-pmid-39305160-vosoritide-v1"></a>

## PubMed record PMID 39305160

> PeptideScanner retained PubMed bibliographic metadata for PMID 39305160 at 2026-07-30T16:14:08.845Z. PubMed recorded a metadata revision date of 2026-06-30 and an Entrez history date of 2024-09-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-39305160-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39305160-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-39305160-vosoritide-v1
- Content SHA-256: `ae12c710bd7e6e03b18dec460c5459f950c32f8d003abf59edc7abe4be26b263`

### Claims and source pins

#### Headline

PubMed record PMID 39305160 ([`pubmed-observation-pmid-39305160-2026-06-30-0bda761345aa`](#source-pubmed-observation-pmid-39305160-2026-06-30-0bda761345aa))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 39305160 at 2026-07-30T16:14:08.845Z. PubMed recorded a metadata revision date of 2026-06-30 and an Entrez history date of 2024-09-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39305160-2026-06-30-0bda761345aa`](#source-pubmed-observation-pmid-39305160-2026-06-30-0bda761345aa))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 39305160 at 2026-07-30T16:14:08.845Z. PubMed recorded a metadata revision date of 2026-06-30 and an Entrez history date of 2024-09-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39305160-2026-06-30-0bda761345aa`](#source-pubmed-observation-pmid-39305160-2026-06-30-0bda761345aa))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39305160-2026-06-30-0bda761345aa`](#source-pubmed-observation-pmid-39305160-2026-06-30-0bda761345aa))

### Sources

<a id="source-pubmed-observation-pmid-39305160-2026-06-30-0bda761345aa"></a>
- **PubMed record PMID 39305160 · retained source version 1:2026-06-30:current:0bda761345aae8bbc6a78ffa55a5421f805c1140084e7282548a8b6d5bbae1d0** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39305160/) (`pubmed-observation-pmid-39305160-2026-06-30-0bda761345aa`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 39305160." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-39305160-vosoritide-v1 SHA-256: ae12c710bd7e6e03b18dec460c5459f950c32f8d003abf59edc7abe4be26b263.

---

<a id="pubmed-pmid-39399714-vosoritide-v1"></a>

## Vosoritide therapy in children with achondroplasia under 5 years of age.

> PubMed lists PMID 39399714 in Translational pediatrics as Editorial, Comment, with publication-date metadata of 2024-09-11 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39399714-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-10-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39399714-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-39399714-vosoritide-v1
- Content SHA-256: `49fe494d19f8a4ce206922f41eadf6cb142d62da4ff7719c7eb93f4e05c0f492`

### Claims and source pins

#### Headline

Vosoritide therapy in children with achondroplasia under 5 years of age. ([`pubmed-observation-pmid-39399714-2024-10-15-9a2858135bc6`](#source-pubmed-observation-pmid-39399714-2024-10-15-9a2858135bc6))

#### Summary

PubMed lists PMID 39399714 in Translational pediatrics as Editorial, Comment, with publication-date metadata of 2024-09-11 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39399714-2024-10-15-9a2858135bc6`](#source-pubmed-observation-pmid-39399714-2024-10-15-9a2858135bc6))

#### Paragraph 1

PubMed lists PMID 39399714 in Translational pediatrics as Editorial, Comment, with publication-date metadata of 2024-09-11 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39399714-2024-10-15-9a2858135bc6`](#source-pubmed-observation-pmid-39399714-2024-10-15-9a2858135bc6))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39399714-2024-10-15-9a2858135bc6`](#source-pubmed-observation-pmid-39399714-2024-10-15-9a2858135bc6))

### Sources

<a id="source-pubmed-observation-pmid-39399714-2024-10-15-9a2858135bc6"></a>
- **Vosoritide therapy in children with achondroplasia under 5 years of age. · retained source version 1:2024-10-15:current:9a2858135bc6c8ba0438e22075b540880f790ca352714f88aa9ef9a5f9ad9d08** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39399714/) (`pubmed-observation-pmid-39399714-2024-10-15-9a2858135bc6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide therapy in children with achondroplasia under 5 years of age." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-39399714-vosoritide-v1 SHA-256: 49fe494d19f8a4ce206922f41eadf6cb142d62da4ff7719c7eb93f4e05c0f492.

---

<a id="pubmed-pmid-39740666-vosoritide-v1"></a>

## PubMed record PMID 39740666

> PeptideScanner retained PubMed bibliographic metadata for PMID 39740666 at 2026-07-30T16:14:08.917Z. PubMed recorded a metadata revision date of 2026-06-07 and an Entrez history date of 2024-12-31. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-39740666-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-07
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39740666-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-39740666-vosoritide-v1
- Content SHA-256: `18144a28b2413360ce496aa80aa4073cb35a3eab0dff69371979913901d2a8a1`

### Claims and source pins

#### Headline

PubMed record PMID 39740666 ([`pubmed-observation-pmid-39740666-2026-06-07-42f504e8d513`](#source-pubmed-observation-pmid-39740666-2026-06-07-42f504e8d513))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 39740666 at 2026-07-30T16:14:08.917Z. PubMed recorded a metadata revision date of 2026-06-07 and an Entrez history date of 2024-12-31. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39740666-2026-06-07-42f504e8d513`](#source-pubmed-observation-pmid-39740666-2026-06-07-42f504e8d513))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 39740666 at 2026-07-30T16:14:08.917Z. PubMed recorded a metadata revision date of 2026-06-07 and an Entrez history date of 2024-12-31. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39740666-2026-06-07-42f504e8d513`](#source-pubmed-observation-pmid-39740666-2026-06-07-42f504e8d513))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39740666-2026-06-07-42f504e8d513`](#source-pubmed-observation-pmid-39740666-2026-06-07-42f504e8d513))

### Sources

<a id="source-pubmed-observation-pmid-39740666-2026-06-07-42f504e8d513"></a>
- **PubMed record PMID 39740666 · retained source version 1:2026-06-07:current:42f504e8d5133aff627934b01e4fd6a4328008ac1d8bfbe3d8b049d1c83021fc** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39740666/) (`pubmed-observation-pmid-39740666-2026-06-07-42f504e8d513`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 39740666." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-39740666-vosoritide-v1 SHA-256: 18144a28b2413360ce496aa80aa4073cb35a3eab0dff69371979913901d2a8a1.

---

<a id="pubmed-pmid-39864410-vosoritide-v1"></a>

## PubMed record PMID 39864410

> PeptideScanner retained PubMed bibliographic metadata for PMID 39864410 at 2026-07-30T16:14:08.934Z. PubMed recorded a metadata revision date of 2026-06-03 and an Entrez history date of 2025-01-26. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-39864410-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39864410-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-39864410-vosoritide-v1
- Content SHA-256: `08366e9c0740ce789ce018f8dd1f9ccda4b21e4f7b090bc0323e0dfebb184156`

### Claims and source pins

#### Headline

PubMed record PMID 39864410 ([`pubmed-observation-pmid-39864410-2026-06-03-a074d700ebea`](#source-pubmed-observation-pmid-39864410-2026-06-03-a074d700ebea))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 39864410 at 2026-07-30T16:14:08.934Z. PubMed recorded a metadata revision date of 2026-06-03 and an Entrez history date of 2025-01-26. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39864410-2026-06-03-a074d700ebea`](#source-pubmed-observation-pmid-39864410-2026-06-03-a074d700ebea))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 39864410 at 2026-07-30T16:14:08.934Z. PubMed recorded a metadata revision date of 2026-06-03 and an Entrez history date of 2025-01-26. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39864410-2026-06-03-a074d700ebea`](#source-pubmed-observation-pmid-39864410-2026-06-03-a074d700ebea))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39864410-2026-06-03-a074d700ebea`](#source-pubmed-observation-pmid-39864410-2026-06-03-a074d700ebea))

### Sources

<a id="source-pubmed-observation-pmid-39864410-2026-06-03-a074d700ebea"></a>
- **PubMed record PMID 39864410 · retained source version 1:2026-06-03:current:a074d700ebeafc973788e31859f3ccb5b592e3affa936b993c0fe52faf38c108** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39864410/) (`pubmed-observation-pmid-39864410-2026-06-03-a074d700ebea`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 39864410." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-39864410-vosoritide-v1 SHA-256: 08366e9c0740ce789ce018f8dd1f9ccda4b21e4f7b090bc0323e0dfebb184156.

---

<a id="pubmed-pmid-40099812-vosoritide-v1"></a>

## PubMed record PMID 40099812

> PeptideScanner retained PubMed bibliographic metadata for PMID 40099812 at 2026-07-30T16:14:10.937Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-03-18. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-40099812-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-09
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40099812-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-40099812-vosoritide-v1
- Content SHA-256: `48137135b9c9b9ecdb204ec8fbcd180f9159f4a177f5030a4908c518320c22aa`

### Claims and source pins

#### Headline

PubMed record PMID 40099812 ([`pubmed-observation-pmid-40099812-2026-06-09-cfaac31c2e2b`](#source-pubmed-observation-pmid-40099812-2026-06-09-cfaac31c2e2b))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 40099812 at 2026-07-30T16:14:10.937Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-03-18. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40099812-2026-06-09-cfaac31c2e2b`](#source-pubmed-observation-pmid-40099812-2026-06-09-cfaac31c2e2b))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 40099812 at 2026-07-30T16:14:10.937Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-03-18. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40099812-2026-06-09-cfaac31c2e2b`](#source-pubmed-observation-pmid-40099812-2026-06-09-cfaac31c2e2b))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40099812-2026-06-09-cfaac31c2e2b`](#source-pubmed-observation-pmid-40099812-2026-06-09-cfaac31c2e2b))

### Sources

<a id="source-pubmed-observation-pmid-40099812-2026-06-09-cfaac31c2e2b"></a>
- **PubMed record PMID 40099812 · retained source version 1:2026-06-09:current:cfaac31c2e2b2fd65adb959799244e112a9f0498adfb0b1c61566ba45d4b6561** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40099812/) (`pubmed-observation-pmid-40099812-2026-06-09-cfaac31c2e2b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 40099812." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-40099812-vosoritide-v1 SHA-256: 48137135b9c9b9ecdb204ec8fbcd180f9159f4a177f5030a4908c518320c22aa.

---

<a id="pubmed-pmid-40821249-vosoritide-v1"></a>

## Vosoritide (Voxzogo) for Achondroplasia: A Review of Clinical and Real-World Evidence.

> PubMed lists PMID 40821249 in Cureus as Journal Article, Review, with publication-date metadata of 2025-07-15 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-40821249-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-09-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40821249-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-40821249-vosoritide-v1
- Content SHA-256: `146dc8518c78e1c6bda0d4a41fbab5c91a22c49c844efe337b559934b3d2f1b8`

### Claims and source pins

#### Headline

Vosoritide (Voxzogo) for Achondroplasia: A Review of Clinical and Real-World Evidence. ([`pubmed-observation-pmid-40821249-2025-09-14-4938cf1e9128`](#source-pubmed-observation-pmid-40821249-2025-09-14-4938cf1e9128))

#### Summary

PubMed lists PMID 40821249 in Cureus as Journal Article, Review, with publication-date metadata of 2025-07-15 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40821249-2025-09-14-4938cf1e9128`](#source-pubmed-observation-pmid-40821249-2025-09-14-4938cf1e9128))

#### Paragraph 1

PubMed lists PMID 40821249 in Cureus as Journal Article, Review, with publication-date metadata of 2025-07-15 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40821249-2025-09-14-4938cf1e9128`](#source-pubmed-observation-pmid-40821249-2025-09-14-4938cf1e9128))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40821249-2025-09-14-4938cf1e9128`](#source-pubmed-observation-pmid-40821249-2025-09-14-4938cf1e9128))

### Sources

<a id="source-pubmed-observation-pmid-40821249-2025-09-14-4938cf1e9128"></a>
- **Vosoritide (Voxzogo) for Achondroplasia: A Review of Clinical and Real-World Evidence. · retained source version 1:2025-09-14:current:4938cf1e9128c471ca8d22eb6eaa0171dcec187c891f924c24a2e7274a85a8b9** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40821249/) (`pubmed-observation-pmid-40821249-2025-09-14-4938cf1e9128`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide (Voxzogo) for Achondroplasia: A Review of Clinical and Real-World Evidence." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-40821249-vosoritide-v1 SHA-256: 146dc8518c78e1c6bda0d4a41fbab5c91a22c49c844efe337b559934b3d2f1b8.

---

<a id="pubmed-pmid-41078071-vosoritide-v1"></a>

## Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report.

> PubMed lists PMID 41078071 in Hormone research in paediatrics as Case Reports, Journal Article, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41078071-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41078071-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41078071-vosoritide-v1
- Content SHA-256: `4afc4f51e8746018a108b3460bf836dbc1b7cadf72d0a967c9acd23ce642fb82`

### Claims and source pins

#### Headline

Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report. ([`pubmed-observation-pmid-41078071-2025-11-21-bdd8317a0587`](#source-pubmed-observation-pmid-41078071-2025-11-21-bdd8317a0587))

#### Summary

PubMed lists PMID 41078071 in Hormone research in paediatrics as Case Reports, Journal Article, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41078071-2025-11-21-bdd8317a0587`](#source-pubmed-observation-pmid-41078071-2025-11-21-bdd8317a0587))

#### Paragraph 1

PubMed lists PMID 41078071 in Hormone research in paediatrics as Case Reports, Journal Article, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41078071-2025-11-21-bdd8317a0587`](#source-pubmed-observation-pmid-41078071-2025-11-21-bdd8317a0587))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41078071-2025-11-21-bdd8317a0587`](#source-pubmed-observation-pmid-41078071-2025-11-21-bdd8317a0587))

### Sources

<a id="source-pubmed-observation-pmid-41078071-2025-11-21-bdd8317a0587"></a>
- **Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report. · retained source version 1:2025-11-21:current:bdd8317a058752ace60dd5def00e9684f8974b5db82671dcc639eec3b6437a78** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41078071/) (`pubmed-observation-pmid-41078071-2025-11-21-bdd8317a0587`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41078071-vosoritide-v1 SHA-256: 4afc4f51e8746018a108b3460bf836dbc1b7cadf72d0a967c9acd23ce642fb82.

---

<a id="pubmed-pmid-41157964-vosoritide-v1"></a>

## PubMed record PMID 41157964

> PeptideScanner retained PubMed bibliographic metadata for PMID 41157964 at 2026-07-30T16:22:16.190Z. PubMed recorded a metadata revision date of 2026-04-21 and an Entrez history date of 2025-10-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41157964-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41157964-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41157964-vosoritide-v1
- Content SHA-256: `e31d840b4d4a083ae37f2861bf1e9b3f535ac470021a023a1f38e1598da21a84`

### Claims and source pins

#### Headline

PubMed record PMID 41157964 ([`pubmed-observation-pmid-41157964-2026-04-21-f471e9eef6ff`](#source-pubmed-observation-pmid-41157964-2026-04-21-f471e9eef6ff))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41157964 at 2026-07-30T16:22:16.190Z. PubMed recorded a metadata revision date of 2026-04-21 and an Entrez history date of 2025-10-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41157964-2026-04-21-f471e9eef6ff`](#source-pubmed-observation-pmid-41157964-2026-04-21-f471e9eef6ff))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41157964 at 2026-07-30T16:22:16.190Z. PubMed recorded a metadata revision date of 2026-04-21 and an Entrez history date of 2025-10-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41157964-2026-04-21-f471e9eef6ff`](#source-pubmed-observation-pmid-41157964-2026-04-21-f471e9eef6ff))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41157964-2026-04-21-f471e9eef6ff`](#source-pubmed-observation-pmid-41157964-2026-04-21-f471e9eef6ff))

### Sources

<a id="source-pubmed-observation-pmid-41157964-2026-04-21-f471e9eef6ff"></a>
- **PubMed record PMID 41157964 · retained source version 1:2026-04-21:current:f471e9eef6ffc76548bb5609bf4beaf48c0255dce027f0c473bfb8891770eb7c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41157964/) (`pubmed-observation-pmid-41157964-2026-04-21-f471e9eef6ff`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41157964." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41157964-vosoritide-v1 SHA-256: e31d840b4d4a083ae37f2861bf1e9b3f535ac470021a023a1f38e1598da21a84.

---

<a id="pubmed-pmid-41340868-vosoritide-v1"></a>

## Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide.

> PubMed lists PMID 41340868 in Genetics in medicine open as Journal Article, with publication-date metadata of 2025-10-13 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41340868-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-12-06
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41340868-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41340868-vosoritide-v1
- Content SHA-256: `8f0ce208f23167ba675923da9151ff82a419256bde280a2ccb1cf0d1adc7b3c3`

### Claims and source pins

#### Headline

Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide. ([`pubmed-observation-pmid-41340868-2025-12-06-41eb6dc0e2d4`](#source-pubmed-observation-pmid-41340868-2025-12-06-41eb6dc0e2d4))

#### Summary

PubMed lists PMID 41340868 in Genetics in medicine open as Journal Article, with publication-date metadata of 2025-10-13 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41340868-2025-12-06-41eb6dc0e2d4`](#source-pubmed-observation-pmid-41340868-2025-12-06-41eb6dc0e2d4))

#### Paragraph 1

PubMed lists PMID 41340868 in Genetics in medicine open as Journal Article, with publication-date metadata of 2025-10-13 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41340868-2025-12-06-41eb6dc0e2d4`](#source-pubmed-observation-pmid-41340868-2025-12-06-41eb6dc0e2d4))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41340868-2025-12-06-41eb6dc0e2d4`](#source-pubmed-observation-pmid-41340868-2025-12-06-41eb6dc0e2d4))

### Sources

<a id="source-pubmed-observation-pmid-41340868-2025-12-06-41eb6dc0e2d4"></a>
- **Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide. · retained source version 1:2025-12-06:current:41eb6dc0e2d47be6ed2a7b30cfaf650280ec382b5a9c4fa147effdbf8cd0a30c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41340868/) (`pubmed-observation-pmid-41340868-2025-12-06-41eb6dc0e2d4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41340868-vosoritide-v1 SHA-256: 8f0ce208f23167ba675923da9151ff82a419256bde280a2ccb1cf0d1adc7b3c3.

---

<a id="pubmed-pmid-41424367-vosoritide-v1"></a>

## PubMed record PMID 41424367

> PeptideScanner retained PubMed bibliographic metadata for PMID 41424367 at 2026-08-10T10:49:08.725Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-12-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41424367-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-30
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41424367-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41424367-vosoritide-v1
- Content SHA-256: `8ba6843deb492a46c0264a08a1875a3a401c995beff5e0051f3155f956b9b085`

### Claims and source pins

#### Headline

PubMed record PMID 41424367 ([`pubmed-observation-pmid-41424367-2026-07-30-133b5b1977c6`](#source-pubmed-observation-pmid-41424367-2026-07-30-133b5b1977c6))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41424367 at 2026-08-10T10:49:08.725Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-12-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41424367-2026-07-30-133b5b1977c6`](#source-pubmed-observation-pmid-41424367-2026-07-30-133b5b1977c6))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41424367 at 2026-08-10T10:49:08.725Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-12-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41424367-2026-07-30-133b5b1977c6`](#source-pubmed-observation-pmid-41424367-2026-07-30-133b5b1977c6))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41424367-2026-07-30-133b5b1977c6`](#source-pubmed-observation-pmid-41424367-2026-07-30-133b5b1977c6))

### Sources

<a id="source-pubmed-observation-pmid-41424367-2026-07-30-133b5b1977c6"></a>
- **PubMed record PMID 41424367 · retained source version 1:2026-07-30:current:133b5b1977c6b7a1032f995152bb2fa98b16d18c0b18e71a9b1b01016a034b3b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41424367/) (`pubmed-observation-pmid-41424367-2026-07-30-133b5b1977c6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41424367." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41424367-vosoritide-v1 SHA-256: 8ba6843deb492a46c0264a08a1875a3a401c995beff5e0051f3155f956b9b085.

---

<a id="pubmed-pmid-41610120-vosoritide-v1"></a>

## PubMed record PMID 41610120

> PeptideScanner retained PubMed bibliographic metadata for PMID 41610120 at 2026-07-30T16:11:44.897Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41610120-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41610120-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41610120-vosoritide-v1
- Content SHA-256: `399cf710804f2e0766ad26c975402249807600cf2c43d6b1aafadd36aa953a93`

### Claims and source pins

#### Headline

PubMed record PMID 41610120 ([`pubmed-observation-pmid-41610120-2026-07-01-68c1197f7213`](#source-pubmed-observation-pmid-41610120-2026-07-01-68c1197f7213))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41610120 at 2026-07-30T16:11:44.897Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41610120-2026-07-01-68c1197f7213`](#source-pubmed-observation-pmid-41610120-2026-07-01-68c1197f7213))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41610120 at 2026-07-30T16:11:44.897Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41610120-2026-07-01-68c1197f7213`](#source-pubmed-observation-pmid-41610120-2026-07-01-68c1197f7213))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41610120-2026-07-01-68c1197f7213`](#source-pubmed-observation-pmid-41610120-2026-07-01-68c1197f7213))

### Sources

<a id="source-pubmed-observation-pmid-41610120-2026-07-01-68c1197f7213"></a>
- **PubMed record PMID 41610120 · retained source version 1:2026-07-01:current:68c1197f7213fe5cfa16a47b0ea3fe6743610c71c8acdfb2333eb61efc76223b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41610120/) (`pubmed-observation-pmid-41610120-2026-07-01-68c1197f7213`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41610120." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41610120-vosoritide-v1 SHA-256: 399cf710804f2e0766ad26c975402249807600cf2c43d6b1aafadd36aa953a93.

---

<a id="pubmed-pmid-41615893-vosoritide-v1"></a>

## PubMed record PMID 41615893

> PeptideScanner retained PubMed bibliographic metadata for PMID 41615893 at 2026-07-30T16:22:18.348Z. PubMed recorded a metadata revision date of 2026-04-04 and an Entrez history date of 2026-01-30. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41615893-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-04
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41615893-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41615893-vosoritide-v1
- Content SHA-256: `9727bf628e101cf856bade3b62f50cc2ccc8c01eb8032c79e4a7a9ffd6a07143`

### Claims and source pins

#### Headline

PubMed record PMID 41615893 ([`pubmed-observation-pmid-41615893-2026-04-04-d82d7efcdee3`](#source-pubmed-observation-pmid-41615893-2026-04-04-d82d7efcdee3))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41615893 at 2026-07-30T16:22:18.348Z. PubMed recorded a metadata revision date of 2026-04-04 and an Entrez history date of 2026-01-30. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41615893-2026-04-04-d82d7efcdee3`](#source-pubmed-observation-pmid-41615893-2026-04-04-d82d7efcdee3))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41615893 at 2026-07-30T16:22:18.348Z. PubMed recorded a metadata revision date of 2026-04-04 and an Entrez history date of 2026-01-30. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41615893-2026-04-04-d82d7efcdee3`](#source-pubmed-observation-pmid-41615893-2026-04-04-d82d7efcdee3))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41615893-2026-04-04-d82d7efcdee3`](#source-pubmed-observation-pmid-41615893-2026-04-04-d82d7efcdee3))

### Sources

<a id="source-pubmed-observation-pmid-41615893-2026-04-04-d82d7efcdee3"></a>
- **PubMed record PMID 41615893 · retained source version 1:2026-04-04:current:d82d7efcdee3dad7597d6e8f773294c9d29cdaa0b588d2e64de36bb2a9eb256b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41615893/) (`pubmed-observation-pmid-41615893-2026-04-04-d82d7efcdee3`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41615893." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41615893-vosoritide-v1 SHA-256: 9727bf628e101cf856bade3b62f50cc2ccc8c01eb8032c79e4a7a9ffd6a07143.

---

<a id="pubmed-pmid-41621839-vosoritide-v1"></a>

## PubMed record PMID 41621839

> PeptideScanner retained PubMed bibliographic metadata for PMID 41621839 at 2026-08-10T18:13:40.584Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-02-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41621839-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-06
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41621839-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41621839-vosoritide-v1
- Content SHA-256: `f1991477c8f77378c060ad5abb16647de2f436fb1187f2299fd5f9199fc48a60`

### Claims and source pins

#### Headline

PubMed record PMID 41621839 ([`pubmed-observation-pmid-41621839-2026-07-06-cf83994ff081`](#source-pubmed-observation-pmid-41621839-2026-07-06-cf83994ff081))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41621839 at 2026-08-10T18:13:40.584Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-02-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41621839-2026-07-06-cf83994ff081`](#source-pubmed-observation-pmid-41621839-2026-07-06-cf83994ff081))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41621839 at 2026-08-10T18:13:40.584Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-02-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41621839-2026-07-06-cf83994ff081`](#source-pubmed-observation-pmid-41621839-2026-07-06-cf83994ff081))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41621839-2026-07-06-cf83994ff081`](#source-pubmed-observation-pmid-41621839-2026-07-06-cf83994ff081))

### Sources

<a id="source-pubmed-observation-pmid-41621839-2026-07-06-cf83994ff081"></a>
- **PubMed record PMID 41621839 · retained source version 1:2026-07-06:current:cf83994ff0811c239b45c90759df658c06b12aac08ca399b564d4f3d982284a2** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41621839/) (`pubmed-observation-pmid-41621839-2026-07-06-cf83994ff081`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41621839." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41621839-vosoritide-v1 SHA-256: f1991477c8f77378c060ad5abb16647de2f436fb1187f2299fd5f9199fc48a60.

---

<a id="pubmed-pmid-41762856-vosoritide-v1"></a>

## PubMed record PMID 41762856

> PeptideScanner retained PubMed bibliographic metadata for PMID 41762856 at 2026-08-10T18:13:42.759Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-02-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41762856-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-09
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41762856-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41762856-vosoritide-v1
- Content SHA-256: `8ed6e36b1f0f5df20de1eace712804b626aa83dfe7731d72a40148aff6b179af`

### Claims and source pins

#### Headline

PubMed record PMID 41762856 ([`pubmed-observation-pmid-41762856-2026-07-09-926c9f58f0ec`](#source-pubmed-observation-pmid-41762856-2026-07-09-926c9f58f0ec))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41762856 at 2026-08-10T18:13:42.759Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-02-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41762856-2026-07-09-926c9f58f0ec`](#source-pubmed-observation-pmid-41762856-2026-07-09-926c9f58f0ec))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41762856 at 2026-08-10T18:13:42.759Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-02-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41762856-2026-07-09-926c9f58f0ec`](#source-pubmed-observation-pmid-41762856-2026-07-09-926c9f58f0ec))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41762856-2026-07-09-926c9f58f0ec`](#source-pubmed-observation-pmid-41762856-2026-07-09-926c9f58f0ec))

### Sources

<a id="source-pubmed-observation-pmid-41762856-2026-07-09-926c9f58f0ec"></a>
- **PubMed record PMID 41762856 · retained source version 1:2026-07-09:current:926c9f58f0ec1ec947124fe3fbe5c24f5cc31beae10a7d6f6129d129e8203243** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41762856/) (`pubmed-observation-pmid-41762856-2026-07-09-926c9f58f0ec`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41762856." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41762856-vosoritide-v1 SHA-256: 8ed6e36b1f0f5df20de1eace712804b626aa83dfe7731d72a40148aff6b179af.

---

<a id="pubmed-pmid-41764752-vosoritide-v1"></a>

## PubMed record PMID 41764752

> PeptideScanner retained PubMed bibliographic metadata for PMID 41764752 at 2026-08-10T10:49:08.778Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-03-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41764752-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-31
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41764752-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41764752-vosoritide-v1
- Content SHA-256: `03e2c64a25cd91f3cb3c501a25484ef1d37338f014a891d366afa039615deb0e`

### Claims and source pins

#### Headline

PubMed record PMID 41764752 ([`pubmed-observation-pmid-41764752-2026-07-31-793ca33d4df3`](#source-pubmed-observation-pmid-41764752-2026-07-31-793ca33d4df3))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41764752 at 2026-08-10T10:49:08.778Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-03-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41764752-2026-07-31-793ca33d4df3`](#source-pubmed-observation-pmid-41764752-2026-07-31-793ca33d4df3))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41764752 at 2026-08-10T10:49:08.778Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-03-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41764752-2026-07-31-793ca33d4df3`](#source-pubmed-observation-pmid-41764752-2026-07-31-793ca33d4df3))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41764752-2026-07-31-793ca33d4df3`](#source-pubmed-observation-pmid-41764752-2026-07-31-793ca33d4df3))

### Sources

<a id="source-pubmed-observation-pmid-41764752-2026-07-31-793ca33d4df3"></a>
- **PubMed record PMID 41764752 · retained source version 1:2026-07-31:current:793ca33d4df3e5d3048b58d975d2a4a3981171b27a0e452c97d0c06b44c44bd8** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41764752/) (`pubmed-observation-pmid-41764752-2026-07-31-793ca33d4df3`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41764752." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41764752-vosoritide-v1 SHA-256: 03e2c64a25cd91f3cb3c501a25484ef1d37338f014a891d366afa039615deb0e.

---

<a id="pubmed-pmid-41783511-vosoritide-v1"></a>

## PubMed record PMID 41783511

> PeptideScanner retained PubMed bibliographic metadata for PMID 41783511 at 2026-07-30T16:23:41.272Z. PubMed recorded a metadata revision date of 2026-03-05 and an Entrez history date of 2026-03-05. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41783511-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-03-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41783511-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41783511-vosoritide-v1
- Content SHA-256: `49a2e1590c10938d8c6115d8b3d9854d5e256af991d15a13c478962a37e9d09a`

### Claims and source pins

#### Headline

PubMed record PMID 41783511 ([`pubmed-observation-pmid-41783511-2026-03-05-2923bccec646`](#source-pubmed-observation-pmid-41783511-2026-03-05-2923bccec646))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41783511 at 2026-07-30T16:23:41.272Z. PubMed recorded a metadata revision date of 2026-03-05 and an Entrez history date of 2026-03-05. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41783511-2026-03-05-2923bccec646`](#source-pubmed-observation-pmid-41783511-2026-03-05-2923bccec646))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41783511 at 2026-07-30T16:23:41.272Z. PubMed recorded a metadata revision date of 2026-03-05 and an Entrez history date of 2026-03-05. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41783511-2026-03-05-2923bccec646`](#source-pubmed-observation-pmid-41783511-2026-03-05-2923bccec646))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41783511-2026-03-05-2923bccec646`](#source-pubmed-observation-pmid-41783511-2026-03-05-2923bccec646))

### Sources

<a id="source-pubmed-observation-pmid-41783511-2026-03-05-2923bccec646"></a>
- **PubMed record PMID 41783511 · retained source version 1:2026-03-05:current:2923bccec646830792d35e49c5411f94546d7cd2642a1fa91f1e5509d6ede42d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41783511/) (`pubmed-observation-pmid-41783511-2026-03-05-2923bccec646`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41783511." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41783511-vosoritide-v1 SHA-256: 49a2e1590c10938d8c6115d8b3d9854d5e256af991d15a13c478962a37e9d09a.

---

<a id="pubmed-pmid-41810698-vosoritide-v1"></a>

## PubMed record PMID 41810698

> PeptideScanner retained PubMed bibliographic metadata for PMID 41810698 at 2026-08-10T18:13:44.816Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2026-03-11. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41810698-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-23
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41810698-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41810698-vosoritide-v1
- Content SHA-256: `93608243386427389da968a1c9d253740bef1bd0ef2a253cf37dc41418631cf5`

### Claims and source pins

#### Headline

PubMed record PMID 41810698 ([`pubmed-observation-pmid-41810698-2026-07-23-7df4c0ec52c6`](#source-pubmed-observation-pmid-41810698-2026-07-23-7df4c0ec52c6))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41810698 at 2026-08-10T18:13:44.816Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2026-03-11. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41810698-2026-07-23-7df4c0ec52c6`](#source-pubmed-observation-pmid-41810698-2026-07-23-7df4c0ec52c6))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41810698 at 2026-08-10T18:13:44.816Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2026-03-11. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41810698-2026-07-23-7df4c0ec52c6`](#source-pubmed-observation-pmid-41810698-2026-07-23-7df4c0ec52c6))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41810698-2026-07-23-7df4c0ec52c6`](#source-pubmed-observation-pmid-41810698-2026-07-23-7df4c0ec52c6))

### Sources

<a id="source-pubmed-observation-pmid-41810698-2026-07-23-7df4c0ec52c6"></a>
- **PubMed record PMID 41810698 · retained source version 1:2026-07-23:current:7df4c0ec52c680371854c11962ddb5f287aa1473520c2e52737c649e009a5eb1** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41810698/) (`pubmed-observation-pmid-41810698-2026-07-23-7df4c0ec52c6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41810698." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41810698-vosoritide-v1 SHA-256: 93608243386427389da968a1c9d253740bef1bd0ef2a253cf37dc41418631cf5.

---

<a id="pubmed-pmid-41967490-vosoritide-v1"></a>

## PubMed record PMID 41967490

> PeptideScanner retained PubMed bibliographic metadata for PMID 41967490 at 2026-07-30T16:22:18.495Z. PubMed recorded a metadata revision date of 2026-04-12 and an Entrez history date of 2026-04-12. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41967490-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-12
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41967490-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41967490-vosoritide-v1
- Content SHA-256: `f63fd8de2c0249d965f1d262469c97361f9948963c819ea06bd10797dc9ca563`

### Claims and source pins

#### Headline

PubMed record PMID 41967490 ([`pubmed-observation-pmid-41967490-2026-04-12-23adeb386e1a`](#source-pubmed-observation-pmid-41967490-2026-04-12-23adeb386e1a))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41967490 at 2026-07-30T16:22:18.495Z. PubMed recorded a metadata revision date of 2026-04-12 and an Entrez history date of 2026-04-12. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41967490-2026-04-12-23adeb386e1a`](#source-pubmed-observation-pmid-41967490-2026-04-12-23adeb386e1a))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41967490 at 2026-07-30T16:22:18.495Z. PubMed recorded a metadata revision date of 2026-04-12 and an Entrez history date of 2026-04-12. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41967490-2026-04-12-23adeb386e1a`](#source-pubmed-observation-pmid-41967490-2026-04-12-23adeb386e1a))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41967490-2026-04-12-23adeb386e1a`](#source-pubmed-observation-pmid-41967490-2026-04-12-23adeb386e1a))

### Sources

<a id="source-pubmed-observation-pmid-41967490-2026-04-12-23adeb386e1a"></a>
- **PubMed record PMID 41967490 · retained source version 1:2026-04-12:current:23adeb386e1aff101eaaf9bb1456e3ed9f2e5d22bb334dc338e212bc81c1f428** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41967490/) (`pubmed-observation-pmid-41967490-2026-04-12-23adeb386e1a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41967490." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-41967490-vosoritide-v1 SHA-256: f63fd8de2c0249d965f1d262469c97361f9948963c819ea06bd10797dc9ca563.

---

<a id="pubmed-pmid-42001280-vosoritide-v1"></a>

## PubMed record PMID 42001280

> PeptideScanner retained PubMed bibliographic metadata for PMID 42001280 at 2026-08-10T18:13:48.756Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-04-19. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42001280-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-17
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42001280-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42001280-vosoritide-v1
- Content SHA-256: `e32bd6c9620cdc81205f830e5b20ba1f8f27dfa5e35635fc8adcaa76c62d4d1b`

### Claims and source pins

#### Headline

PubMed record PMID 42001280 ([`pubmed-observation-pmid-42001280-2026-07-17-d13c7e4684c0`](#source-pubmed-observation-pmid-42001280-2026-07-17-d13c7e4684c0))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42001280 at 2026-08-10T18:13:48.756Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-04-19. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42001280-2026-07-17-d13c7e4684c0`](#source-pubmed-observation-pmid-42001280-2026-07-17-d13c7e4684c0))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42001280 at 2026-08-10T18:13:48.756Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-04-19. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42001280-2026-07-17-d13c7e4684c0`](#source-pubmed-observation-pmid-42001280-2026-07-17-d13c7e4684c0))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42001280-2026-07-17-d13c7e4684c0`](#source-pubmed-observation-pmid-42001280-2026-07-17-d13c7e4684c0))

### Sources

<a id="source-pubmed-observation-pmid-42001280-2026-07-17-d13c7e4684c0"></a>
- **PubMed record PMID 42001280 · retained source version 1:2026-07-17:current:d13c7e4684c0808ba54f6d268293802dfa012ebe5a2cffff64b165576f3fd237** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42001280/) (`pubmed-observation-pmid-42001280-2026-07-17-d13c7e4684c0`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42001280." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42001280-vosoritide-v1 SHA-256: e32bd6c9620cdc81205f830e5b20ba1f8f27dfa5e35635fc8adcaa76c62d4d1b.

---

<a id="pubmed-pmid-42026358-vosoritide-v1"></a>

## PubMed record PMID 42026358

> PeptideScanner retained PubMed bibliographic metadata for PMID 42026358 at 2026-08-10T10:49:08.854Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-04-23. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42026358-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-06
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42026358-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42026358-vosoritide-v1
- Content SHA-256: `6c0721dd5c7f1a45e14b8938e8146bb8c49abeb2930a713cd464052f8aff1d34`

### Claims and source pins

#### Headline

PubMed record PMID 42026358 ([`pubmed-observation-pmid-42026358-2026-08-06-ad67351be298`](#source-pubmed-observation-pmid-42026358-2026-08-06-ad67351be298))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42026358 at 2026-08-10T10:49:08.854Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-04-23. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42026358-2026-08-06-ad67351be298`](#source-pubmed-observation-pmid-42026358-2026-08-06-ad67351be298))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42026358 at 2026-08-10T10:49:08.854Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-04-23. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42026358-2026-08-06-ad67351be298`](#source-pubmed-observation-pmid-42026358-2026-08-06-ad67351be298))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42026358-2026-08-06-ad67351be298`](#source-pubmed-observation-pmid-42026358-2026-08-06-ad67351be298))

### Sources

<a id="source-pubmed-observation-pmid-42026358-2026-08-06-ad67351be298"></a>
- **PubMed record PMID 42026358 · retained source version 1:2026-08-06:current:ad67351be29829bc3aa970eeb5bc2fc3884983b54590d93235b94887a385110d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42026358/) (`pubmed-observation-pmid-42026358-2026-08-06-ad67351be298`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42026358." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42026358-vosoritide-v1 SHA-256: 6c0721dd5c7f1a45e14b8938e8146bb8c49abeb2930a713cd464052f8aff1d34.

---

<a id="pubmed-pmid-42043535-vosoritide-v1"></a>

## PubMed record PMID 42043535

> PeptideScanner retained PubMed bibliographic metadata for PMID 42043535 at 2026-07-30T16:20:43.712Z. PubMed recorded a metadata revision date of 2026-05-22 and an Entrez history date of 2026-04-27. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42043535-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42043535-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42043535-vosoritide-v1
- Content SHA-256: `55f944603aec56f7bf10cff6b14b814455567c4f273e5349c1af2a45167ab908`

### Claims and source pins

#### Headline

PubMed record PMID 42043535 ([`pubmed-observation-pmid-42043535-2026-05-22-7f49f855f194`](#source-pubmed-observation-pmid-42043535-2026-05-22-7f49f855f194))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42043535 at 2026-07-30T16:20:43.712Z. PubMed recorded a metadata revision date of 2026-05-22 and an Entrez history date of 2026-04-27. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42043535-2026-05-22-7f49f855f194`](#source-pubmed-observation-pmid-42043535-2026-05-22-7f49f855f194))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42043535 at 2026-07-30T16:20:43.712Z. PubMed recorded a metadata revision date of 2026-05-22 and an Entrez history date of 2026-04-27. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42043535-2026-05-22-7f49f855f194`](#source-pubmed-observation-pmid-42043535-2026-05-22-7f49f855f194))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42043535-2026-05-22-7f49f855f194`](#source-pubmed-observation-pmid-42043535-2026-05-22-7f49f855f194))

### Sources

<a id="source-pubmed-observation-pmid-42043535-2026-05-22-7f49f855f194"></a>
- **PubMed record PMID 42043535 · retained source version 1:2026-05-22:current:7f49f855f1949e6ad4fcf70bb821cf87b5de70b435065d0345b904c8c1bd476d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42043535/) (`pubmed-observation-pmid-42043535-2026-05-22-7f49f855f194`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42043535." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42043535-vosoritide-v1 SHA-256: 55f944603aec56f7bf10cff6b14b814455567c4f273e5349c1af2a45167ab908.

---

<a id="pubmed-pmid-42238253-vosoritide-v1"></a>

## PubMed record PMID 42238253

> PeptideScanner retained PubMed bibliographic metadata for PMID 42238253 at 2026-07-30T16:14:18.068Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42238253-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-04
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42238253-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42238253-vosoritide-v1
- Content SHA-256: `53defd79c1f63cec3dc33de09f28aba5a1944420141dc49f749e9a0e76539ffb`

### Claims and source pins

#### Headline

PubMed record PMID 42238253 ([`pubmed-observation-pmid-42238253-2026-06-04-188b8525410c`](#source-pubmed-observation-pmid-42238253-2026-06-04-188b8525410c))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42238253 at 2026-07-30T16:14:18.068Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42238253-2026-06-04-188b8525410c`](#source-pubmed-observation-pmid-42238253-2026-06-04-188b8525410c))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42238253 at 2026-07-30T16:14:18.068Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42238253-2026-06-04-188b8525410c`](#source-pubmed-observation-pmid-42238253-2026-06-04-188b8525410c))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42238253-2026-06-04-188b8525410c`](#source-pubmed-observation-pmid-42238253-2026-06-04-188b8525410c))

### Sources

<a id="source-pubmed-observation-pmid-42238253-2026-06-04-188b8525410c"></a>
- **PubMed record PMID 42238253 · retained source version 1:2026-06-04:current:188b8525410c41347f67114f78fc447c8e330196c0f81ffd36d2a9b759543ca4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42238253/) (`pubmed-observation-pmid-42238253-2026-06-04-188b8525410c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42238253." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42238253-vosoritide-v1 SHA-256: 53defd79c1f63cec3dc33de09f28aba5a1944420141dc49f749e9a0e76539ffb.

---

<a id="pubmed-pmid-42479670-vosoritide-v1"></a>

## PubMed record PMID 42479670

> PeptideScanner retained PubMed bibliographic metadata for PMID 42479670 at 2026-08-10T18:13:56.698Z. PubMed recorded a metadata revision date of 2026-07-21 and an Entrez history date of 2026-07-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42479670-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-21
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42479670-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42479670-vosoritide-v1
- Content SHA-256: `91b6db365aa746364770b904055f943599fa32ffa575ff7120f159261dfaa32f`

### Claims and source pins

#### Headline

PubMed record PMID 42479670 ([`pubmed-observation-pmid-42479670-2026-07-21-b10359bf926a`](#source-pubmed-observation-pmid-42479670-2026-07-21-b10359bf926a))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42479670 at 2026-08-10T18:13:56.698Z. PubMed recorded a metadata revision date of 2026-07-21 and an Entrez history date of 2026-07-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42479670-2026-07-21-b10359bf926a`](#source-pubmed-observation-pmid-42479670-2026-07-21-b10359bf926a))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42479670 at 2026-08-10T18:13:56.698Z. PubMed recorded a metadata revision date of 2026-07-21 and an Entrez history date of 2026-07-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42479670-2026-07-21-b10359bf926a`](#source-pubmed-observation-pmid-42479670-2026-07-21-b10359bf926a))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42479670-2026-07-21-b10359bf926a`](#source-pubmed-observation-pmid-42479670-2026-07-21-b10359bf926a))

### Sources

<a id="source-pubmed-observation-pmid-42479670-2026-07-21-b10359bf926a"></a>
- **PubMed record PMID 42479670 · retained source version 1:2026-07-21:current:b10359bf926ab9d6cd4f3c77a99b66ea44f6459a64d4fe789225bc245adb25a9** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42479670/) (`pubmed-observation-pmid-42479670-2026-07-21-b10359bf926a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42479670." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42479670-vosoritide-v1 SHA-256: 91b6db365aa746364770b904055f943599fa32ffa575ff7120f159261dfaa32f.

---

<a id="pubmed-pmid-42495828-vosoritide-v1"></a>

## PubMed record PMID 42495828

> PeptideScanner retained PubMed bibliographic metadata for PMID 42495828 at 2026-08-10T18:13:56.737Z. PubMed recorded a metadata revision date of 2026-07-24 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42495828-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-24
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42495828-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42495828-vosoritide-v1
- Content SHA-256: `ee18c486f94887f325dba63b13b6b4c1febd75c80246bd5e28342655718d25ba`

### Claims and source pins

#### Headline

PubMed record PMID 42495828 ([`pubmed-observation-pmid-42495828-2026-07-24-a76f317aaa0d`](#source-pubmed-observation-pmid-42495828-2026-07-24-a76f317aaa0d))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42495828 at 2026-08-10T18:13:56.737Z. PubMed recorded a metadata revision date of 2026-07-24 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42495828-2026-07-24-a76f317aaa0d`](#source-pubmed-observation-pmid-42495828-2026-07-24-a76f317aaa0d))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42495828 at 2026-08-10T18:13:56.737Z. PubMed recorded a metadata revision date of 2026-07-24 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42495828-2026-07-24-a76f317aaa0d`](#source-pubmed-observation-pmid-42495828-2026-07-24-a76f317aaa0d))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42495828-2026-07-24-a76f317aaa0d`](#source-pubmed-observation-pmid-42495828-2026-07-24-a76f317aaa0d))

### Sources

<a id="source-pubmed-observation-pmid-42495828-2026-07-24-a76f317aaa0d"></a>
- **PubMed record PMID 42495828 · retained source version 1:2026-07-24:current:a76f317aaa0d889c674c616fa37e7ff867e24eebfd67a14f57c3e69986aa6b68** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42495828/) (`pubmed-observation-pmid-42495828-2026-07-24-a76f317aaa0d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42495828." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42495828-vosoritide-v1 SHA-256: ee18c486f94887f325dba63b13b6b4c1febd75c80246bd5e28342655718d25ba.

---

<a id="pubmed-pmid-42518139-vosoritide-v1"></a>

## PubMed record PMID 42518139

> PeptideScanner retained PubMed bibliographic metadata for PMID 42518139 at 2026-08-10T18:13:56.769Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42518139-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-29
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42518139-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42518139-vosoritide-v1
- Content SHA-256: `4d3df80b588c39fb2a2955fd5ac5f87a6a215be1adf1fd0170a6f7719271453a`

### Claims and source pins

#### Headline

PubMed record PMID 42518139 ([`pubmed-observation-pmid-42518139-2026-07-29-d5297ec0887c`](#source-pubmed-observation-pmid-42518139-2026-07-29-d5297ec0887c))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42518139 at 2026-08-10T18:13:56.769Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42518139-2026-07-29-d5297ec0887c`](#source-pubmed-observation-pmid-42518139-2026-07-29-d5297ec0887c))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42518139 at 2026-08-10T18:13:56.769Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42518139-2026-07-29-d5297ec0887c`](#source-pubmed-observation-pmid-42518139-2026-07-29-d5297ec0887c))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42518139-2026-07-29-d5297ec0887c`](#source-pubmed-observation-pmid-42518139-2026-07-29-d5297ec0887c))

### Sources

<a id="source-pubmed-observation-pmid-42518139-2026-07-29-d5297ec0887c"></a>
- **PubMed record PMID 42518139 · retained source version 1:2026-07-29:current:d5297ec0887c017e033bae8f9121854ab352feb3dadbc9b89275556915fa2cf9** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42518139/) (`pubmed-observation-pmid-42518139-2026-07-29-d5297ec0887c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42518139." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42518139-vosoritide-v1 SHA-256: 4d3df80b588c39fb2a2955fd5ac5f87a6a215be1adf1fd0170a6f7719271453a.

---

<a id="pubmed-pmid-42519733-vosoritide-v1"></a>

## PubMed record PMID 42519733

> PeptideScanner retained PubMed bibliographic metadata for PMID 42519733 at 2026-08-10T18:13:56.777Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42519733-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-29
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42519733-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42519733-vosoritide-v1
- Content SHA-256: `cb83c9e5b1602a36fbda4d5d9f7619eaf67a93c7594d75e327aadc20ad500fb7`

### Claims and source pins

#### Headline

PubMed record PMID 42519733 ([`pubmed-observation-pmid-42519733-2026-07-29-b07e664515aa`](#source-pubmed-observation-pmid-42519733-2026-07-29-b07e664515aa))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42519733 at 2026-08-10T18:13:56.777Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42519733-2026-07-29-b07e664515aa`](#source-pubmed-observation-pmid-42519733-2026-07-29-b07e664515aa))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42519733 at 2026-08-10T18:13:56.777Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42519733-2026-07-29-b07e664515aa`](#source-pubmed-observation-pmid-42519733-2026-07-29-b07e664515aa))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42519733-2026-07-29-b07e664515aa`](#source-pubmed-observation-pmid-42519733-2026-07-29-b07e664515aa))

### Sources

<a id="source-pubmed-observation-pmid-42519733-2026-07-29-b07e664515aa"></a>
- **PubMed record PMID 42519733 · retained source version 1:2026-07-29:current:b07e664515aa96704d30480616cdb2372583348f3cda9e731a694685eecebf14** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42519733/) (`pubmed-observation-pmid-42519733-2026-07-29-b07e664515aa`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42519733." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42519733-vosoritide-v1 SHA-256: cb83c9e5b1602a36fbda4d5d9f7619eaf67a93c7594d75e327aadc20ad500fb7.

---

<a id="pubmed-pmid-42713641-vosoritide-v1"></a>

## A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia.

> PubMed lists PMID 42713641 in NEJM evidence as Journal Article, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42713641-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-09-09
- Source checked: 2026-09-09
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42713641-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42713641-vosoritide-v1
- Content SHA-256: `24f7cc3ebb863986640e258c9771769f2f21db47f0e67422b5a881cf4255cfb6`

### Claims and source pins

#### Headline

A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia. ([`pubmed-observation-pmid-42713641-2026-09-09-3296b303c913`](#source-pubmed-observation-pmid-42713641-2026-09-09-3296b303c913))

#### Summary

PubMed lists PMID 42713641 in NEJM evidence as Journal Article, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42713641-2026-09-09-3296b303c913`](#source-pubmed-observation-pmid-42713641-2026-09-09-3296b303c913))

#### Paragraph 1

PubMed lists PMID 42713641 in NEJM evidence as Journal Article, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42713641-2026-09-09-3296b303c913`](#source-pubmed-observation-pmid-42713641-2026-09-09-3296b303c913))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42713641-2026-09-09-3296b303c913`](#source-pubmed-observation-pmid-42713641-2026-09-09-3296b303c913))

### Sources

<a id="source-pubmed-observation-pmid-42713641-2026-09-09-3296b303c913"></a>
- **A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia. · retained source version 1:2026-09-09:current:3296b303c9139f7f941f253495615824e23db2faf2f9883190a3e6c174b16ec4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42713641/) (`pubmed-observation-pmid-42713641-2026-09-09-3296b303c913`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42713641-vosoritide-v1 SHA-256: 24f7cc3ebb863986640e258c9771769f2f21db47f0e67422b5a881cf4255cfb6.

---

<a id="pubmed-pmid-42713641-vosoritide-v2"></a>

## A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia.

> PubMed lists PMID 42713641 in NEJM evidence as Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42713641-vosoritide:v2`
- Evidence domain: Literature metadata
- Date in source: 2026-11-09
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42713641-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42713641-vosoritide-v2
- Content SHA-256: `36f53c85056a132493bd9db33731c88f8ee5400148461b4df398996dfdcc6ca9`

### Claims and source pins

#### Headline

A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia. ([`pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2`](#source-pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2))

#### Summary

PubMed lists PMID 42713641 in NEJM evidence as Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2`](#source-pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2))

#### Paragraph 1

PubMed lists PMID 42713641 in NEJM evidence as Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2`](#source-pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2`](#source-pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2))

### Sources

<a id="source-pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2"></a>
- **A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia. · retained source version 1:2026-11-09:current:661fc7a368b93a94cbf38f0f500a456e1c3435412041e6d46715a17783bed724** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42713641/) (`pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2`)

### Correction lineage

updated on 2026-11-16: PubMed revised the bibliographic metadata of PMID 42713641, with a metadata revision date of 2026-11-09. This version reports that observation; the earlier retained observation remains available as version 1.
- Supersedes version: 1
- Correction sources: [`pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2`](#source-pubmed-observation-pmid-42713641-2026-09-09-3296b303c913-r2)

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia." Version 2, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42713641-vosoritide-v2 SHA-256: 36f53c85056a132493bd9db33731c88f8ee5400148461b4df398996dfdcc6ca9.

---

<a id="pubmed-pmid-42825290-vosoritide-v1"></a>

## Early closure of cranial base synchondroses in infants with Vosoritide-treated achondroplasia.

> PubMed lists PMID 42825290 in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology as Journal Article, with publication-date metadata of 2026-07-16 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42825290-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-03
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42825290-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42825290-vosoritide-v1
- Content SHA-256: `d223ded7f944b5f990da8b903c9b99ac05173238826d8bc51e0fc75a57d13166`

### Claims and source pins

#### Headline

Early closure of cranial base synchondroses in infants with Vosoritide-treated achondroplasia. ([`pubmed-observation-pmid-42825290-2026-10-03-5b19e3648d97`](#source-pubmed-observation-pmid-42825290-2026-10-03-5b19e3648d97))

#### Summary

PubMed lists PMID 42825290 in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology as Journal Article, with publication-date metadata of 2026-07-16 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42825290-2026-10-03-5b19e3648d97`](#source-pubmed-observation-pmid-42825290-2026-10-03-5b19e3648d97))

#### Paragraph 1

PubMed lists PMID 42825290 in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology as Journal Article, with publication-date metadata of 2026-07-16 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42825290-2026-10-03-5b19e3648d97`](#source-pubmed-observation-pmid-42825290-2026-10-03-5b19e3648d97))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42825290-2026-10-03-5b19e3648d97`](#source-pubmed-observation-pmid-42825290-2026-10-03-5b19e3648d97))

### Sources

<a id="source-pubmed-observation-pmid-42825290-2026-10-03-5b19e3648d97"></a>
- **Early closure of cranial base synchondroses in infants with Vosoritide-treated achondroplasia. · retained source version 1:2026-10-03:current:5b19e3648d97a9565f00341b1a035ae4c0dbb385c9ed775f692a5f2f2c62ab1f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42825290/) (`pubmed-observation-pmid-42825290-2026-10-03-5b19e3648d97`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Early closure of cranial base synchondroses in infants with Vosoritide-treated achondroplasia." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42825290-vosoritide-v1 SHA-256: d223ded7f944b5f990da8b903c9b99ac05173238826d8bc51e0fc75a57d13166.

---

<a id="pubmed-pmid-42983735-vosoritide-v1"></a>

## Vosoritide therapy in Brazil: Consensus on the Diagnosis, Monitoring, and Management of Achondroplasia.

> PubMed lists PMID 42983735 in Orphanet journal of rare diseases as Journal Article, Consensus Statement, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-08-06 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42983735-vosoritide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-11-06
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42983735-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42983735-vosoritide-v1
- Content SHA-256: `b34ed7632eefde5206fb63ef432462d442ac63862df186555c469c2e53eedced`

### Claims and source pins

#### Headline

Vosoritide therapy in Brazil: Consensus on the Diagnosis, Monitoring, and Management of Achondroplasia. ([`pubmed-observation-pmid-42983735-2026-11-06-f33202b44673`](#source-pubmed-observation-pmid-42983735-2026-11-06-f33202b44673))

#### Summary

PubMed lists PMID 42983735 in Orphanet journal of rare diseases as Journal Article, Consensus Statement, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-08-06 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42983735-2026-11-06-f33202b44673`](#source-pubmed-observation-pmid-42983735-2026-11-06-f33202b44673))

#### Paragraph 1

PubMed lists PMID 42983735 in Orphanet journal of rare diseases as Journal Article, Consensus Statement, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-08-06 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42983735-2026-11-06-f33202b44673`](#source-pubmed-observation-pmid-42983735-2026-11-06-f33202b44673))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42983735-2026-11-06-f33202b44673`](#source-pubmed-observation-pmid-42983735-2026-11-06-f33202b44673))

### Sources

<a id="source-pubmed-observation-pmid-42983735-2026-11-06-f33202b44673"></a>
- **Vosoritide therapy in Brazil: Consensus on the Diagnosis, Monitoring, and Management of Achondroplasia. · retained source version 1:2026-11-06:current:f33202b44673d372e02e01e4cd3e29de64c17b3f570a2f466d8bb0323fc6d4fe** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42983735/) (`pubmed-observation-pmid-42983735-2026-11-06-f33202b44673`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Vosoritide therapy in Brazil: Consensus on the Diagnosis, Monitoring, and Management of Achondroplasia." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/vosoritide.json#pubmed-pmid-42983735-vosoritide-v1 SHA-256: b34ed7632eefde5206fb63ef432462d442ac63862df186555c469c2e53eedced.

